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Exclusionary policy hard 
to understand
I write concerning the article 
[Yale Medicine, Winter 2017] 
on the distinguished late 
Carolyn Slayman, Ph.D., deputy 
dean for scientific affairs. The 
article includes a description 
of her earning her Ph.D. at 
Rockefeller University, “where 
only one woman was admit-
ted to each entering class 
of 15. At a dinner at the home 
of the president, a classmate 
asked why this was so, and the 
answer came back, ‘Because 
that is the right number.’ ” 
(Presumably, this was in the 
early 1960s.)
I find such a gender exclu-
sionary policy difficult to under-
stand, and perhaps now it is out 
of date. 
I much enjoyed Yale Medicine 
and the coverage of its broad 
activities in which the school 
is engaged. Please keep me on 
your mailing list.
James B.D. Mark, M.D., HS ’60 
Professor of Cardiothoracic 
Surgery Emeritus, Stanford 
University School of Medicine, 
Stanford, Calif.
Medicine and the 
humanities
Congratulations on the excellent 
Yale Medicine, Winter 2017 edi-
tion. I was interested in the com-
ment, page 21, regarding the Yale 
Medical Symphony Orchestra, 
along with the picture on pages 
36-37 of the quartet. In about 
1970, when my prior mentor 
Philip Bondy, M.D., was chair 
of medicine, he invited me to 
return to Yale to give a seminar. 
He told me he could not join me 
for dinner because of another 
engagement. When I wandered 
through Harkness Hall to meet a 
friend, there was Phil leading and 
participating in a string quartet 
with students. Faculty involve-
ment with students in making 
music certainly goes back to 
the Bondy era. It is always good 
to read about the Yale School 
of Medicine and to learn how it 
remains a leader in education, 
research, and humanity.
James Scheuer, M.D. ’56 
University Chair of Medicine 
Emeritus, Distinguished Profes-
sor of Medicine Emeritus, Albert 
Einstein College of Medicine  
and Montefiore Medical Center
We can do better with 
single-payer
Cathy Shufro’s review of 
EMBRACE, by Gilead Lancaster, 
M.D. [Yale Medicine, Winter 
2017], encouraged me to read 
it. Although well-intended, the 
author made two significant 
errors in his approach to uni-
versal health coverage. He 
strongly believes that for-profit 
insurers still have a role, even 
after years of bad experience 
by patients, hospitals, and 
physicians. For-profit insurers 
are known for cherry-picking 
customers, steering patients 
away from specialists, and deny-
ing and rationing care for profit. 
Second, he favorably compares 
his approach to the Canadian 
single-payer program and leaves 
out H.R. 676, Expanded and 
Improved Medicare for All Act, 
which has 79 co-sponsors in the 
U.S. Congress. With input from 
Physicians for a National Health 
Program (PNHP.org), H.R. 676 
offers comprehensive care for 
all, is not linked to employment, 
and would establish a universal 
single-payer health care system. 
This means medical, surgical, 
mental health, dental, prescrip-
tions, hospitals, and long-term 
care, with no out-of-pocket 
costs. Numerous studies have 
demonstrated that this could 
be done with the same amount 
currently spent on health care. 
In 2013, United Health axed  
their contract with the 
1,200-physician Yale Medicine 
practice, causing harm to many. 
We can do better with single-
payer simplicity.
Harvey Fernbach, M.D., 
M.P.H. ’71, Physicians for a  
National Health Program
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  The medical  
 school and the city
m at the w n emerson, m.p.p.m. ’81,  grew up in 
New Haven, spending many an hour in a laboratory at 
the School of Medicine where his father, Yale Nemerson, 
M.D., was a leading researcher in the science of blood clot-
ting. After college and stints in journalism and politics, 
Matthew Nemerson returned to New Haven where he was 
the founding vice president at Science Park, and president 
and CEO of the Chamber of Commerce. Now the city’s eco-
nomic development administrator, Nemerson spoke with 
Yale Medicine recently about the relationship between the 
School of Medicine and the city of New Haven.
How do you see the School of Medicine’s role in the city? I think the 
school has always tried to balance world-class research in basic sci-
ence with a commitment to helping the diverse and often needy com-
munity outside its front door. My dad could go from the molecular 
level of factor XII to manning the MASH tents at the protests on May 
Day 1970. 
What role has the School of Medicine played in the city’s economy? For 
more than half a century, a lot of redevelopment in the city has had 
to do with reconnecting the medical campus to downtown. Basic 
research and thinking about medicine from a “Big Science” stand-
point have been strategically important to Yale since the 1950s, and 
giving the Cedar Street campus room to grow and bring in federal 
research dollars was part of the motivation behind building the Route 
34 Connector.
Do you see the city emerging as a bioscience hub? The city’s challenge is 
to match the enormity of Yale’s bioscience research with an economic 
foundation that can support startup activity, attract commercial talent, 
and keep companies here. We have to be competitive with Cambridge 
and San Francisco and other great bioscience and research centers.
How has New Haven benefited from the bioscience industry? I see the 
biosciences as having a huge multiplier effect. We have dozens of 
bioscience companies and the med center itself that provide jobs and 
stimulate the economy. We have restaurants, unique boutiques, and 
popular entertainment venues. We have a wonderful assortment of 
housing. A world class stature in bioscience is a key driver of our 



















   Deputy dean  
  for diversity
during his undergraduate days at the University 
of California, Berkeley, Darin A. Latimore, M.D., felt like 
an outsider. He was out of his socioeconomic league. A 
debilitating autoimmune disease kept his mother, a home 
health aide, from working, so Latimore had an after-
school job, paid the bills, shopped for groceries, and ran 
the household. His classmates didn’t know what to make 
of a black student who was majoring in microbiology and 
immunology and didn’t play sports. While they debated 
whether to buy a BMW or a Volvo, he drove a rattletrap 
with mismatched tires. 
 
Even before entering college, he 
had received little encouragement. 
His high school English teacher 
told him he’d flunk out of Berkeley 
because he wrote so poorly. His 
family discouraged him from 
attending such an elite institution 
and urged him to go to community 
college so that he could continue 
to contribute financially.
He blossomed as a student 
and resident at the University 
of California Davis School 
of Medicine, where men-
tors encouraged his passion 
for teaching and potential for 
leadership. Nevertheless, dur-
ing residency he felt a need to 
prove himself to colleagues 
and patients, some of whom 
objected to being treated by a 
black doctor. Latimore initially 
shied away from academic 
medicine and instead worked 
with HIV/AIDS patients, becom-
ing a staff physician with The 
Permanente Medical Group in 
South Sacramento. There, he 
trained medical students and 
residents, many of whom shared 
his experiences of isolation and 
discrimination. Hoping to cre-
ate a more welcoming environ-
ment, he wrote a job description 
that led to his inaugural position 
as director of medical student 
diversity at UC Davis in 2008.
“The first time I met Darin 
he gave a presentation on being 
black and gay, and I was so 
impressed at how he portrayed 
his experience and shared it 
with others,” said Nicole Sitkin, 
then an undergrad at Davis 
and now a third-year medi-
cal student at Yale who chairs 
the Dean’s Advisory Council 
on LGBTQI+ Affairs. Latimore 
rose to become associate dean of 
student and resident diversity, 
helping to expand the definition 
of diversity to include underrep-
resented Asian-American groups 
and those who are economically 
disadvantaged. When he started, 
about 20 percent of medical stu-
dents at UC Davis were black  
or Latino. By the end of his  
tenure, approximately 43 per-
cent of UC Davis medical stu-
dents met his broader definition 
of diversity.
Now he holds a similar posi-
tion at Yale, where he’s the medi-
cal school’s first chief diversity 
officer. His job is to address 
the lack of gender and minor-
ity diversity—especially among 
faculty—and improve a climate 
that many view as less than 
inclusive and respectful. In doing 
so, he will apply a broad defini-
tion of diversity that includes 
gender, gender identity, sexual 
yalemedicine.yale.edu4
chronicle
his vision goes beyond provid-
ing health care—he believes that 
Yale has an obligation to partner 
with the New Haven community 
to address issues of education, 
poverty, and unemployment.
Since his arrival in January, 
Latimore has met with depart-
ment chairs to learn how they 
view diversity and inclusion 
and to identify problems. At the 
same time, faculty, residents, 
graduate students, postdoctoral 
fellows, and students from the 
schools of medicine, nursing, 
and public health have sought 
him out. “Everyone wants a 
light shined on an issue,” he 
said, whether it’s leadership, 
inequality, a need for transpar-
ency, or a desire to be heard  
and respected.
Latimore is working with 
such groups as the Minority 
Organization for Retention and 
Expansion; the Committee on 
the Status of Women in Medicine; 
the Committee for Diversity, 
Inclusion, and Social Justice; and 
the Dean’s Advisory Council 
on LGBTQI+ Affairs. Under 
his stewardship, the Office of 
Multicultural Affairs will become 
Diversity, Inclusion, Community, 
and Equity, with an expanded 
staff to make it accessible to a 
larger number of students. He 
has begun standardizing fac-
ulty search criteria and plans 
to implement unconscious bias 
training for search committees, 
eventually expanding it to all 
faculty members. Over the longer 
The first deputy dean 
for diversity and inclu-
sion, Darin Latimore, 
defines diversity 
with a broad sweep 
to include gender, 
gender identity, sexual 
orientation, ethnicity, 
socioeconomic status,  
disadvantaged indi-
viduals, and those who 
are differently abled. 
orientation, ethnicity, socioeco-
nomic status, and those who have 
different abilities.
Although medical school 
faculty diversity in the United 
States has been increasing, it 
has not kept pace with the 
diversity of medical students 
or society in general. At the 
School of Medicine, almost half 
the students are women and 
60 percent are nonwhite. At the 
assistant professor level, 47 per-
cent of faculty are women and 
30 percent are nonwhite. But the 
higher up on the career ladder, 
the further those numbers fall. 
Fewer than a quarter of profes-
sors are women, and just 14 per-
cent are nonwhite. 
But Latimore sees his role 
expanding outside the medical 
campus. At a recent town hall, 
Latimore was on a fact-finding 
mission to hear about student 
and faculty concerns regarding 
diversity, inclusion, and social 
justice. To his surprise, about a 
third of those attending came 
from New Haven’s black and 
Latino communities, and their 
unexpected presence changed 
the conversation. Latimore, who 
is in his element in front of a 
crowd, not only rolled with the 
change in plan but embraced it. 
“Diversity is the easy part,” he 
said, “because it’s just numbers.” 
Inclusion, on the other hand, 
means fostering a culture in 
which people have the tools they 
need to succeed. While he told 
his audience that he will partner 
with New Haven residents to lift 



















students who made that first 
cut then went on to prepare 
their pitches with one-on-one 
help from staff at the Office of 
Career Strategy, which spon-
sored the competition. Matthew 
Piva, a graduate student in 
neuroscience and a McDougal 
Graduate Career Fellow, orga-
nized the event with four other 
McDougal Fellows.
The idea for the three-
minute (3MT) competition 
emerged from the University 
of Queensland in Australia in 
2008. Over the next two years 
it spread to other universities in 
Australia and New Zealand, and 
since 2011, 3MT competitions 
have been held at more than 
350 universities in 59 countries. 
This was the first time one has 
been held at Yale.
Daniel Jones, the only 
humanities student in the 
finals, said that his first draft 
clocked in at 15 minutes. “It 
wasn’t going to work,” he said. 
“I had to take out all the stuff 
I thought was the best stuff.” 
The history student argued that 
corruption and democracy were 
born at the same time, along 
with the concept that a public 
position is not for private gain. 
His slide included a red Make 
America Great Again cap, the 
symbol of Donald Trump’s pres-
idential campaign.
“Being able to communicate 
your research in a short amount 
of time before a non-specialist 
audience is important,” said Lily 
Zeng, a student in the School 
of Forestry & Environmental 
term, his plans include forming a 
diversity committee to develop a 
strategic plan with a timeline and 
metrics to track progress. “We 
need data,” he said. “You do not 
change what you do not measure.”
When Latimore started at 
UC Davis, he assumed he could 
change the world. Today, he 
realizes that change comes 
slowly and is brought about by 
cultivating relationships and 
finding common ground in order 
to move forward. “I believe that 
unless we have an inclusive 
environment, diversity will be 
a revolving door,” he said. “To 
make a long-term dent, we need 
to create an environment where 
everyone feels they can fly.”
—Jill Max
»
A thesis in three minutes
The poster plastered around the 
Yale campus was succinct: Three 
Minutes, One Slide, Big Ideas.
This was the three-minute 
thesis competition. Graduate 
students and postdocs would 
have just 180 seconds to boil 
their research down to its 
basics, with just one slide to 
illustrate their thesis.
On April 13 the 11 finalists in 
the first such competition at Yale 
made their elevator pitches before 
about 50 people in The Anlyan 
Center auditorium. Their research 
ranged from building artificial 
lungs, to the possibility of life 
elsewhere in the universe, to con-
servation issues in China, to the 
origins of the notion of corruption.
“The skills you have perfected 
today will be very valuable 
going forward. Just being able 
to explain what you study to 
your parents, to your friends, to 
your taxi driver will help people 
understand the excitement and 
value of academic research,” 
said Lynn Cooley, Ph.D., dean 
of the Graduate School of Arts 
and Sciences, the C.N.H. Long 
Professor of Genetics, and pro-
fessor of cell biology and of 
molecular, cellular, and devel-
opmental biology.
Cooley led a panel of judges 
that included Eileen O’Connor, 
vice president for commu-
nications at Yale; Angelika 
Hofmann, who teaches a 
course in scientific writing 
for postdocs; and Kyle Gibson, 
a producer for ABC News 
Nightline and winner of several 
Emmy Awards. They ranked 
the students based on criteria 
including the clarity of their 
presentation, the accessibil-
ity of their language, and their 
stage presence.
The first student on deck, 
Alexander Engler, who stud-
ies biomedical engineering, got 
right to the point. “I am here to 
tell you how we can grow you a 
new lung,” he said.
Engler was one of 11 finalists 
in the competition’s third and 
final day. Previous rounds had 
reduced the field from 30 stu-
dents and postdocs. A tie led to 
11 instead of 10 finalists.
The process started weeks 
earlier with proposals from 40 
students and postdocs. The 30 
online exclusives
Just a few months 
into his tenure as the 
School of Medicine’s 
first deputy dean for 
diversity and inclusion, 
Darin Latimore met 
with students, faculty, 
and residents of New 
Haven at a town hall 
on the medical cam-
pus. The talk moved 
away from Yale and 
to relations between 
the med school and 
the city.





a channel in kidneys that nor-
mally sends electrical signals but 
can go awry. “I am searching for 
the key to open the polycystin 
channel in order to send a mes-
sage,” she said.
Levi Smith, a student in cell 
biology, won second place for 
his research on Alzheimer’s dis-
ease. The disease, he said, leads 
to a “dying brain poisoned by 
amyloid beta.”
Yangqi Gu, a student in molec-
ular, cellular, and developmental 
biology, took third place for his 
study of how bacteria defy the 
laws of physics to attach them-
selves to human skin.
—John Curtis
Stavola took first prize, an 
Apple Watch, for her presenta-
tion on finding ways to prevent 
cyst growth in kidneys that can 
enlarge the organ from the size 
of a fist to the size of a football. 
“Imagine if you had to spend the 
rest of your life attached to a 
machine,” she said. Polycystic 
kidney disease, she said, can 
be fatal, requires dialysis, and 
can only be cured through 
transplantation. Her solution 
involves controlling polycystin, 
Studies. Her presentation was 
about reconciling conserva-
tion efforts with social benefits 
for indigenous communities 
when protecting sacred for-
ests in China. “It forces you to 
have a better understanding 
of your own work. It’s really 
easy to hide behind jargon and 
buzzwords.”
Lindsey Stavola, who’s com-
pleting her Ph.D. this year in 
cellular and molecular physi-
ology, found herself rehears-
ing everywhere. While she 
cooked her morning oatmeal 
in her microwave—set to three 
minutes—she ran through her 
presentation. 
Lindsey Stavola, who’s 
about to graduate 
with a degree in cel-
lular and molecular 
physiology, won first 
place for her presenta-
tion on cystic kidney 

















Just days before the 
U.S. missile attack 
on Syria, experts 
discussed the ongoing 
humanitarian crisis 
in that country on 
Global Health Day. It 
has provoked, accord-
ing to experts, the 
worst refugee crisis 
since World War II.




Brain scans as  
predictors of suicide
Suicide is this country’s 10th 
leading cause of death. Among 
teens and young adults, it is the 
second leading cause of death. 
About half of those diagnosed 
with bipolar disorder, whose 
moods swing from manic to 
depressed, will make a suicide 
attempt, and as many as one in 
five will die by their own hands. 
Yet mental health practitioners 
have traditionally had only such 
subjective measures as patient 
interviews to gauge the risk of 
suicide. Now new imaging tech-
nologies can discern brain pat-
terns that suggest an increased 
risk of suicide. 
In a study of patients with 
bipolar disorder, Yale research-
ers led by Hilary P. Blumberg, 
M.D., the John and Hope 
Furth Professor of Psychiatric 
Neuroscience, found three indica-
tors linked to suicidal behavior 
that can be tracked through 
imaging technology.
“The identification of brain 
circuits involved in risk for sui-
cide can lead to new ways to 
identify who is most at risk, and, 
hopefully prevent suicides,” said 
Blumberg of the study published 
in The American Journal of 
Psychiatry, in January.
In their study, researchers 
found that in teenagers and young 
adults with bipolar disorder who 
have made suicide attempts, 
white matter—the brain’s con-
nective wiring—has decreased 
structural integrity in areas that 
regulate emotion. Those who 
attempted suicide also had less 
gray matter in the frontal-limbic 
system where impulses and emo-
tions develop, as well as in the 
frontal cortex, which helps regu-
late those feelings and behav-
ioral responses. Researchers also 
observed a third difference. Using 
measurements of real-time blood 
flow between different areas of 
the brain, an indicator of con-
nectivity and interaction among 
brain regions, they found that 
people who had attempted suicide 
at least once showed less connec-
tivity between the limbic amyg-
dala and the frontal cortex. “The 
findings suggest that the frontal 
cortex is not working as well as it 
should to regulate the circuitry,” 
Blumberg said. “That can lead to 
more extreme emotional pain, 
difficulties in generating alter-
native solutions to suicide, and 
greater likelihood of acting on 
suicidal impulses.” 
Previous research has hinted 
at these findings, but with impor-
tant exceptions, Blumberg said. 
First, very few imaging studies 
have been done in adolescents 
and young adults who have 
attempted suicide. Second, no 
research team thus far has studied 
suicide by evaluating patients via 
three imaging techniques—struc-
tural and functional MRIs and 
diffusion tensor imaging—taken 
in one sitting from a specialized 
MRI machine. 
 The next step will be to 
recruit individuals in other age 
groups as well as those with other 
mental disorders who are at risk 
of suicide, Blumberg said. The 
current study, though it showed 
significant differences between 
groups, was small. It included 
26 participants diagnosed with 
bipolar disorder with at least one 
previous suicide attempt, 42 men 
and women with bipolar disor-
der with no history of suicide 
attempts, and 45 people in a 
healthy comparison group with 
no mental disorder diagnosis and 
no suicide history, all between 
ages 14 and 25.
In the burgeoning field of brain 
imaging, this study “is important 
because it identifies differences in 
brain areas that show who might 
be more likely to act on suicidal 
thoughts,” Blumberg said. Will 
MRI scans of a suicidal and non-
suicidal person reveal differences? 
“We’re not there yet,” Blumberg 
said. “There are no established 
values in brain measurements.” 
That goal still remains the point of 
this research. Blumberg also noted 
that many paths lead toward sui-
cide, from a weakened ability to 
self-regulate emotions to sudden 
tragic life events.
Blumberg and colleagues have 
already initiated research that 
follows adolescents over time to 
record brain changes correlated 
with suicide attempts, and they 
hope to pursue further study. This 
might also provide insight into the 
subjective experiences of suicide 
ideation and why those thoughts 
occur in the first place, she said. 
“Each day we lose people to sui-
cide,” Blumberg said. “We try to 
go as fast as we can—it feels like we 




Genetic variants that have persisted through human evolution 
appear to enhance intellectual accomplishment while increas-
ing the risk of autism spectrum disorders, Yale researchers 
reported in a study published in the journal PLOS Genetics 
in February. The variants appear to have been conserved to 
a greater extent than mere chance would suggest. Typically, 
variants that curtail reproductive success drop out of the gene 
pool quickly, while those that enhance survival remain for gen-
erations. “In this case, we found a strong positive signal that, 
along with autism spectrum disorder, these variants are also 
associated with intellectual achievement,” said first author 
Renato Polimanti, Ph.D., associate research scientist.
“The idea is that during evolution these variants that have 
positive effects on cognitive function were selected, but at a 
cost—in this case, an increased risk of autism spectrum disorders,” 
said co-author Joel Gelernter, M.D., Foundations Fund Professor of 
Psychiatry and professor of genetics and of neuroscience.
GENES CONFER INTELLIGENCE 
… AND INCREASE AUTISM RISK
Fertility, it turns out, depends in part on a sperm’s ability to 
use its tail to move through fluids and navigate the female 
oviduct. Researchers at Yale and Harvard have identified a 
mechanism of this navigational system that when disabled 
reduces male fertility.
The scientists targeted a subunit of an ion channel 
complex that lines the sperm’s tail and helps direct sperm 
on their journey. Removing this single gene in mice disrupted 
the ion channel complex and reduced the sperm’s ability to 
navigate, according to the report published in the journal 
eLife in February.
 These findings could help with treatments for male 
infertility or provide a target for development of male con-
traceptives, said lead author Jean-Ju L. Chung, Ph.D., assis-
tant professor of cellular and molecular physiology.
A BROKEN TAIL SOFTENS 
SPERM’S PUNCH
In 1969 Lassa fever almost killed Jordi Casals-Ariet, M.D., a 
renowned virologist at the School of Public Health. Now Yale 
scientists see the often-fatal virus as a possible cure for ovar-
ian cancer. According to Anthony N. van den Pol, Ph.D., ’77, pro-
fessor of neurosurgery, it’s “like using penicillin from a fungus 
to fight bacteria.” Many human tumors, van den Pol said, lack a 
strong innate immune response, making them susceptible to 
viruses. In mice, he found that a virus based on a combination 
of genes from Lassa virus and vesicular stomatitis virus was 
successful in treating experimental gliomas. Now he’s working 
with Gil Mor, M.D., Ph.D., professor of obstetrics, gynecology, 
and reproductive sciences, to see whether it will have the 
same effect on ovarian cancer. 
“A virus doesn’t have a brain, but it has an evolutionary 
mission to find cells to infect,” van den Pol said. “Viruses rep-
licate and seek and destroy on their own. They don’t need to 
know where the tumors are but seem able to find most if not 
all of them by random ‘attempts’ at infection.”
A DEADLY VIRUS  
RECRUITED TO FIGHT CANCER
Spring 2017 9
a collection of recent  
scientific findings
IN JAN UARY 182 4 ,  the body of a 19-year-old fever victim vanished from her burial 
site in West Haven. The young woman’s outraged family knew immediately where 
to look and headed for the corner of Grove and Prospect streets in New Haven, then 
home to Yale’s medical school. Indeed, the West Haven constable who led the search 
soon found the body hidden under paving stones in the basement. The furor grew, 
and soon some 600 people armed with pistols and daggers were storming the cam-
pus, demanding punishment for the perpetrator, a student who had purloined the 
body to study anatomy. The Governor’s Foot Guard had to quell the riot.
The relationships between the School of Medicine and New Haven have always 
been complex, surpassing the standard town-gown rivalries. While the city has ben-
efited from a world-class medical center, it has also viewed the school with mistrust. 
Too often, people in the community felt that they were seen as guinea pigs for re-
search and nothing more. 
That changed some years ago as medical researchers recognized that promot-
ing good health meant looking beyond the details in a patient’s chart. The social 
determinants of health—where we live, whether we’re poor or well-off, our access 
to health care, the stressors in our lives—all play a role in our well-being. The Robert 
Wood Johnson Foundation Clinical Scholars Program acted on that understanding by 
partnering with New Haven communities to find out which issues were important to 
them and what research needed to be done.
In this issue of Yale Medicine, we take a look at the myriad ways in which the 
presence of the School of Medicine affects the larger New Haven community, from 
taking care of patients and examining the impact of gun violence to promoting the 
city as a hub of biotech research. 
Seeking better health: Yale and New Haven 12
Learning from the community 18
A witness to hunger 24
Mental health, better schools, and the trauma of violence 26
How Yale and New Haven are building a future together 32
Caring for New Haven’s refugees 38
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For years the School of Medicine has worked  
with community organizations to address the  





















In the early 1970s, Maria Me-
lendez, recently arrived from 
Puerto Rico, saw that there 
were no Spanish-speaking 
doctors serving her new 
neighborhood of Fair Haven. 
With others in the communi-
ty as well as local groups, she 
launched a campaign that 
led first to nursing visits and 
then to the establishment of 
the Fair Haven Community 
Health Center.
Seeking better health
maria melendez knew something had to be done.
It was the early 1970s, and New Haven’s Fair Haven 
neighborhood was changing. As Latinos moved into 
the homes once occupied by Irish and Italian blue-
collar families who had moved to the suburbs, health 
care lagged. The neighborhood had no Spanish-
speaking doctors, recalled Melendez, who came to the 
city from Puerto Rico in the mid-1960s to be with her 
husband. The few medical services available tended to 
focus on children.
Determined to meet the larger health needs of 
her community, Melendez joined with members of 
the local chapter of the Alliance for Latin American 
Progress to start a free clinic. The city provided $5,000 
for malpractice insurance and offered the nurse’s office 
at a local elementary school. Volunteers from the Yale 
School of Nursing staffed the makeshift clinic three 
nights a week. The New Haven Foundation, a precursor 
of the Community Foundation for Greater New Haven, 
provided seed money.
“We were looking to provide something more than 
immunizations for the community,” Melendez recalled.
Almost 50 years later, that humble operation has 
grown into the Fair Haven Community Health Center. 
The clinic now treats about 17,500 patients a year at four 
locations and operates five school-based health clin-
ics with an annual budget of about $19 million. Funded 
through a combination of federal and state grants, 
Medicaid, and private insurance, the clinic accepts 
all patients. For $25, uninsured patients—sometimes 
undocumented immigrants—can see a doctor.
“We don’t turn anyone away,” said Suzanne Lagarde, 
M.D., HS ’77, FW ’80, the center’s chief executive offi-
cer, a specialist in gastrointestinal diseases, and a for-
mer faculty member at the School of Medicine.
Fair Haven Community Health Center is just one 
star in a constellation of health organizations created 
in the last 50 years to serve New Haven’s many under-
served residents. They include the even larger Cornell 
Scott-Hill Health Center in the city’s Hill neighbor-
hood, which serves about 36,000 patients a year. 
Provision of health care in New Haven has long linked 
the community with health care providers at Yale. Not 
only have community health centers benefited from 
collaborations with the School of Medicine and Yale 
New Haven Hospital, but Yale clinicians and research-
ers have worked with and learned much from the city’s 
residents while seeking to treat and prevent disease. 
Yale faculty, residents, and students have tackled such 
issues as asthma, traffic, postnatal care, diabetes, drug 
addiction, and HIV/AIDS.
“Our ties to Yale and Yale New Haven Hospital are 
long and deep,” said Michael Taylor, chief executive 
officer of the Cornell Scott-Hill Health Center. “If Yale 
were not here, we would need double the health cen-
ter’s funding.”
Cross-pollination between Yale and the community 
has led to real progress in such areas as infant mortality, 
but health problems persist. New Haven remains a city 
where poverty and chronic diseases are intertwined. 
The city’s minority residents suffer disproportionately 
from such serious and often preventable illnesses as dia-
betes, high blood pressure, obesity, asthma, and heart 
disease. Rates of chronic disease far exceed those of the 
state as a whole and those of surrounding communi-
ties, according to DataHaven, a local nonprofit. In many 
cases, the gap is shockingly wide: 11 percent of New 
Haven’s 130,000 residents have diabetes, compared to 
5 percent in the outer-ring suburbs. More than a fifth of 
city residents suffer from food insecurity, compared to 
7 percent in outer-ring communities.
 A closer look at the data reveals that those prob-
lems are concentrated in the city’s eight poorest 
neighborhoods, all of which have largely minor-
ity populations: West Rock, Newhallville, Dixwell, 
Dwight, West River, the Hill, Fair Haven, and 
Quinnipiac Meadows. About a quarter of the people in 
those neighborhoods suffer from asthma, double the 
state rate, according to a 2015 DataHaven study. The 
incidence of diabetes—13 percent—is nearly twice that 
of the state as a whole.
The economic gap is equally yawning. As of 2015, 
the city’s eight poorest neighborhoods had an unem-
ployment rate of 22 percent compared to 5 percent 
for the rest of the city, according to DataHaven. 
Connecticut may have the nation’s fourth highest 
median household income—$65,753—but that figure 
falls by more than half in neighborhoods like the Hill, 
where the picture grows even bleaker—one area of cen-
tral Fair Haven reports a median household income of 
just $19,485, according to the website City-Data.com. 
Unemployment there is 24 percent, and almost 46 per-
cent of residents live below the poverty line.
 As the saying goes, your ZIP Code reveals more 
about your health than your genetic code.
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looking at the big picture
In the face of such challenges, health care profession-
als and researchers in New Haven have in recent years 
adopted a new approach. They have been incorpo-
rating the realities of their patients’ daily lives into 
treatment plans, said Marjorie S. Rosenthal, M.D. ’95, 
M.P.H., co-director of the National Clinician Scholars 
Program at Yale, and director of the program’s 
Community Research Initiative. The program teaches 
Yale trainees principles of epidemiology and biostatis-
tics, as well as how to work with community partners 
to identify critical challenges to the health of indi-
viduals and communities.
A physician can tell a diabetic to take a daily walk, 
she said, but what if gunfire on the street keeps people 
indoors? And what good is it to recommend a diet that 
includes fresh fruits and vegetables in food deserts 
where produce is unavailable? “If we are not looking 
at the bigger issues, we won’t be able to do our jobs as 
doctors,” Rosenthal said. “This is not just frosting on 
the cake. This is the cake.”
 The approach doesn’t focus only on such nega-
tives as violence, lack of fresh food, and a poor 
understanding of nutrition, Rosenthal added. Medical 
professionals also need to know what works—commu-
nity gardens that provide good inexpensive food, and 
walking trails for exercise—and leverage those posi-
tives, she said.
cooking, gardens, and exercise
Desiree Williams couldn’t get her diabetes under con-
trol. Her A1C glucose level was a sky-high 16, nearly 
three times that of a nondiabetic. She didn’t under-
stand it. She didn’t eat a lot of sweets, so why were her 
numbers so bad?
At the Cornell Scott-Hill Health Center, Williams 
enrolled in a new nutrition and cooking class for 
people with the same problem. It was a revela-
tion. Carbohydrates, she learned, were the culprit. A 
Southerner, Williams was eating way too much of the 
rice that she’d grown up eating. “I wasn’t a junk food 
junkie,” Williams, 56, said. “I was a carb junkie.”
 Williams not only learned what to avoid, but 
how to read labels and cook healthier food. She no 
longer put sugar and other unhealthful ingredients 
in her beloved collard greens. The result: Williams 
cut her A1C glucose level by more than half and lost 
10 pounds. She’s eager to learn even more and wants 
  Maria Melendez
 “To keep growing and growing to  
   what we have become is beyond  
  my imagination. We’ve served  
    the community with pride. 
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Cornell Scott-Hill Health Center to start similar 
classes for pre-diabetic kids.
 “I think I’m going to take every last cooking class 
they have,” Williams said. “It wasn’t like going to 
school. These people were my friends, and they were 
looking out for me.”
 The health center’s six-week cooking and nutri-
tion classes, introduced last year, are part of a growing 
trend in tackling chronic diseases prevalent in New 
Haven’s poorer neighborhoods. The course teaches 
patients which foods to eat, which ones to avoid, how 
to read labels, and how to cook healthier meals, said 
Natalie Lourenco, P.A.-C., director of wellness educa-
tion and outreach at the center.
“I think we all have the goal of treating things holis-
tically, but practically speaking, it’s always a chal-
lenge,” Lourenco said. “People have 15 minutes with 
their doctor, and they’re given a prescription. The 
cooking and nutrition course is an opportunity for us 
to take more time and reinforce the other things that 
need to happen.”
On the other side of the city, Fair Haven Community 
Health Center has a similar program, Lagarde said. The 
center teaches people with diabetes about nutrition 
and cooking, holds exercise classes at an elementary 
school, and encourages people to grow their own veg-
etables at one of the neighborhood’s urban farms, even 
providing a farmer to teach them. “In the fall, we have 
a dinner from the farms,” Lagarde said. “It’s worthy of 
a four-star restaurant.”
Others are expanding the concept. Lee Cruz, a 
director of community outreach at the Community 
Foundation for Greater New Haven and a member of 
the Chatham Square Neighborhood Association in Fair 
Haven, wants doctors to understand the realities of life 
in a poorer community. Physicians need to know the 
difficulties people face in obtaining fresh food, exercis-
ing, and getting to an appointment, he said. But they 
also must understand such community assets as Fair 
Haven’s network of community gardens. That gets 
them “out of their bubbles” and better informs their 
care, he said. That requires more than handing out 
pamphlets and engaging people at a table for 30 sec-
onds. “In my experience,” Cruz said, “what has to hap-
pen is you have to build the relationships first.”
To that end, Cruz has worked with Yale to sponsor 
walking tours of Fair Haven for medical students and 
residents so they can get to know the neighborhood 
and its people. The tours have proven a big hit, he said.
 Cary Gross, M.D., director of the National 
Clinician Scholars Program at Yale, heartily endorses 
Cruz’s approach and the Fair Haven walking tours 
program. It’s just one of many innovative efforts that 
Gross and his colleagues in the scholars program are 
pursuing to better understand and attack the root 
causes of chronic disease and inequity in health and 
health care in New Haven. The approach of focusing 
on specific diseases and identifying the best pharma-
cologic therapy—the biomedical model—has reached 
its limits, Gross said. Medical professionals must 
understand the lives of their patients if they are going 
to make a lasting impact on improving their health 
and well-being, he said.
 “This is one of the things that makes the scholars 
program special—we are training nurses and physi-
cians to conduct research that will drive change. Often, 
we work at these large institutions, but we’re not 
familiar with the surrounding neighborhoods,” Gross 
said. “This is getting us out of the ivory tower and into 
the real world.”
persistent racial and ethnic inequities
When Cruz takes residents and students in the health 
professions on walking tours of Fair Haven, he starts 
along the banks of the Quinnipiac River at a memo-
rial to the 29th Connecticut Colored Regiment, whose 
members served in the Civil War. He wants to remind 
the future doctors of the injustices that black men and 
others have faced in this country. He wants them to 
keep that in mind when they face disproportionate 
rates of chronic illnesses among the city’s minorities.
Addressing those persistent racial and ethnic ineq-
uities is a focus of the Community Foundation for 
Greater New Haven, the region’s largest grantor and a 
longtime supporter of a wide variety of public health 
programs and organizations in the city.
“The community overall is getting healthier,” said 
Christina Ciociola, M.S.W., M.P.H., the community 
foundation’s senior vice president for grant making 
and strategy. “Everyone is getting healthier, but these 
disparities still exist. We’re trying to understand what 
that’s about.”
One way that the foundation is tackling the prob-
lem is the Healthy Start Program that seeks to reduce 
the black infant mortality rate in New Haven. At one 
Seeking better health
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point in the mid-1980s, the city’s infant mortality 
rivaled that of a Third World country, Ciociola said. 
Healthy Start works with mothers to teach them skills 
and connect them with services to assure that their 
babies are healthy and thriving, said Kenn Harris, the 
community foundation’s vice president for community 
engagement and director of New Haven Healthy Start.
The program, which recently celebrated its 20th 
anniversary, has cut the infant mortality rate for black 
babies about in half, Harris said. Mothers who partici-
pate in the program have infant mortality rates lower 
than those in the state’s outer-ring suburbs, he added.
But the program, which accepts mothers of all races 
and ethnicities, has 38 percent black participation, 
below its goal of 50 percent. The reason: blacks are less 
likely to engage with health care professionals. Harris 
attributes that to a long history of medical profession-
als judging blacks. The dearth of black health care pro-
fessionals—Latinos are more likely to encounter Latino 
doctors and nurses—is another factor, he said. He attri-
butes the stubborn inequity in outcomes at least in part 
to the legacy of racism.
“The impact of racism, not just being called a name, 
is still there,” Harris said. “The trauma gets passed on.”
opioids and immigration
For 53-year-old Candida Saunders, the trouble began 
after her mother’s death. She became depressed and 
anxious, and her physician prescribed Xanax. She 
graduated to heroin and soon found herself a full-
blown addict. The drug, she said, is everywhere. “You 
can get it on any street corner,” Saunders said.
 Luckily, Saunders got help. She learned of the 
Cornell Scott-Hill Health Center’s drug rehabilitation 
program and decided it was worth the trek from her 
home in Waterbury. The center put her in treatment 
and on methadone, and she has been off heroin for two 
and a half years. “I came here and got a lot of help that 
I needed,” Saunders said. 
 Ask Taylor, CEO of the Cornell Scott-Hill Health 
Center, about his biggest concern for the future, and 
he answers without hesitation: the crisis of opioid 
abuse. The clinic’s treatment facilities are at capacity 
and would need to triple in size to meet the explod-
ing demand.
 “I will say it’s on everyone’s lips these days,” 
Taylor said. “As a substance use treatment provider, 
we’ve been very aware of increased use for years,  
but the growth we’ve seen in the last year or two is  
off the charts.”
Driving the problem is fentanyl, a highly potent 
cheap synthetic heroin, much of it from Mexico, that 
has flooded the region, Taylor said. It’s also a big con-
cern of the city, especially after 17 overdoses—includ-
ing three fatalities—in one 24-hour period last year, 
said New Haven Director of Health Byron Kennedy, 
M.P.H. ’01, M.D. ’04, Ph.D. ’04. “Something as small 
as a grain of sand could be sufficient to kill a person,” 
Kennedy said.
In Fair Haven, Lagarde said her biggest concern is 
treating undocumented immigrants. The neighbor-
hood has the largest concentration of undocumented 
immigrants in the city, and they make up a significant 
percentage of her clients. President Donald J. Trump’s 
immigration crackdown is pushing those patients into 
the shadows and threatens to make treating them even 
more difficult, she said.
Amid the never-ending challenges, it’s easy to for-
get just how much has been accomplished in the last 
five decades. Maria Melendez hasn’t. She never dreamt 
the small clinic she helped found in an elementary 
school nurse’s office would grow to provide health care 
to thousands of neighborhood residents. 
“To keep growing and growing to what we have 
become is beyond my imagination,” said Melendez, 
who has worked at the clinic since its inception. 
“We’ve served the community with pride.”
Whatever obstacles may lie ahead, Melendez is con-
fident that Fair Haven will meet and overcome them. 
“Our goal when we started was to provide services that 
people need and really appreciate,” she said. “We are 
there to serve the community.” /yale medicine
Christopher Hoffman is a freelance writer in North Haven, Conn.
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During Game Day at New Ha-
ven’s Barnard Environmental 
Studies Magnet School in 
March, Will Boateng of New 
Haven played basketball 
with 6-year-old Carlton Wil-
liams Jr. of West Haven. The 
goal of Game Day is to bring 
the community together.
Learning from the community
about six years ago, the Yale Center for Clinical 
Investigation (YCCI) approached Sandra Trevino, execu-
tive director of Junta for Progressive Action, about part-
nering with Yale in clinical research. Junta is the oldest 
Latino community-based nonprofit organization in 
New Haven, and requests from Yale researchers seeking 
access to the city’s Latino population or to use Junta’s 
name to recruit volunteers were common. But Trevino 
often found the researchers unwilling to share informa-
tion or engage in a meaningful way. Expecting the same 
“one-way street,” Trevino referred the request to a staff 
member and didn’t give it a second thought.
Her resistance turned to enthusiasm, however, 
when YCCI called her, along with other Junta staff 
members and leaders from the African Methodist 
Episcopal (AME) Zion Church. They wanted the com-
munity leaders to provide input on study design and 
recruitment materials for a research project on asthma. 
“I saw they were doing the walk and not just the talk,” 
Trevino says.
When studies include a diverse population and 
engage community members, the research leads to 
more effective treatments and interventions. The 
Cultural Ambassadors program—as YCCI’s collabora-
tion with Junta and the AME Zion Church is known—is 
an example of how Yale researchers engage with New 
Haven’s community, which is more than 60 percent 
black or Latino. 
“Health care providers may not know what it feels 
like to live with a disease and the challenges patients 
face,” says Marjorie S. Rosenthal, M.D. ’95, M.P.H., 
associate professor of pediatrics, co-director of the 
National Clinician Scholars Program (NCSP), and a 
former Robert Woods Johnson Foundation (RWJF) 
Clinical Scholar, who has been involved with research 
in the community. “Researchers have missed the mark 
at times by not asking their research participants about 
those questions before they start the research.” 
Community-engaged research—a collaboration 
between researchers and community partners—is 
gaining ground as an effective way to conduct research 
that will translate into practice. It takes place across 
such School of Medicine departments as emergency 
medicine; internal medicine; laboratory medicine; 
neurology; obstetrics, gynecology, and reproductive 
sciences; pediatrics; and psychiatry; as well as the 
School of Public Health and the School of Nursing. 
Such initiatives as the Cultural Ambassadors program 
and the NCSP—a two-year research fellowship that has 
physicians and nurses working with community mem-
bers—nurture partnerships that pave the way to bet-
ter health. These collaborations have led to increased 
recruitment in clinical trials, improved trust between 
Yale and New Haven residents, and programs that use 
research findings as the basis for interventions that 
improve the health and well-being of the community.
building trust
Like Trevino, Reverend Dr. LeRoy O. Perry Jr., pastor of 
St. Stephens African Methodist Episcopal (AME) Zion 
Church in Branford, Conn., was initially skeptical of 
the Cultural Ambassadors program. He knew the his-
tory of morally questionable research done on blacks 
like the Tuskegee Syphilis Study. Distrust of the medi-
cal establishment has kept nonwhites out of clinical 
trials—they comprise fewer than 5 percent of partici-
pants in studies supported by the National Institutes of 
Health. With minorities suffering disproportionately 
from cancer, diabetes, cardiovascular disease, HIV/
AIDS, and other ailments, their presence in clinical 
studies is crucial. 
In 2008 YCCI learned through focus groups that 
blacks and Latinos were wary of clinical research. People 
who volunteer for clinical trials, participants believed, 
were drug addicts, desperate, uninformed, and incur-
able. Focus group members thought that they would be 
taken advantage of because of their race or class, were 
concerned that research is dangerous, and worried that 
researchers are less than forthcoming about the risks of 
clinical trials. On top of these concerns, discrimination 
and disparities in health care contributed to this mistrust 
of the medical establishment. Focus group participants 
also saw Yale as unapproachable and distant. YCCI took 
heart in one finding, however. Participants indicated that 
they might take part in research if they heard about it 
through family members, friends, churches, health cen-
ters, community centers, or health fairs. 
The Cultural Ambassadors program follows a model 
devised by the Mayo Clinic in Rochester, Minn., in which 
local Hmong residents (refugees from Southeast Asia) 
were enlisted to recruit members of their community for 
clinical research. YCCI expanded on this idea to create 
the Cultural Ambassadors program in 2011 in partner-
ship with Junta, which serves more than 4,600 families, 
and AME Zion, which has 17 local churches serving 5,000 
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families. The first order of business was to host training 
sessions that brought Yale faculty together with Junta 
and AME Zion representatives to discuss the design and 
implementation of research; regulations and laws that 
protect research participants; animal-based research; 
scientific misconduct; and the importance of participat-
ing in clinical research, especially for minorities. “The 
training was essential, because without it, you can’t 
answer questions regarding such issues as safeguards, 
informed consent, anonymity, and efficacy,” says Perry. 
Fielding questions is one way that the Cultural 
Ambassadors inform their communities about clini-
cal research. Through daily contact with parishioners 
and clients, AME Zion pastors and leaders and  
Junta staff members direct people to Yale research 
studies, sometimes even searching for studies online 
at yalestudies.org or calling YCCI to inquire about 
appropriate clinical trials. At fairs and community 
events, they bring their message to large groups of 
people. Armed with fliers and brochures in English 
and Spanish, they meet with people to broach the 
idea of participating in research, and they guide them 
through the process.
Cultural Ambassadors also meet monthly with 
researchers to learn about a study or to weigh in on a 
research protocol. The ambassadors have helped recruit 
participants for studies on the early detection of such 
conditions as learning disabilities, asthma, diabetes, can-
cer, and glaucoma. Many of these studies are aligned with 
health concerns identified as community priorities. 
During these encounters, Cultural Ambassadors and 
















Game Day brought four New 
Haveners together to play  
Sorry: Linda Quinn (in Yale 
sweatshirt); her grandchildren 
Cali’rose Borrero, 18 months,  
and Bella Marie Borrero, 5;  
and Bridgett Williamson.
pepper the researchers with questions, but also explain 
how issues are perceived in their communities and the 
best way to approach potential research volunteers. They 
also advise investigators on study design. In a recent 
meeting about a study to use iPhones to improve diabetes 
management, the group suggested increased surveil-
lance of patients with risk factors, intake interviews to 
assess barriers to care management, and a buddy system 
in which a friend or relative would receive alerts about a 
patient’s blood sugar. “I really feel like it is a true part-
nership, where our voices do matter and what we say is 
making a difference in the decisions that are being made 
in this larger institution,” says Trevino, who, along with 
other Cultural Ambassadors, has appeared in recruitment 
ads for clinical research. 
The program, which has recently been adopted at 
Duke University, has improved minority participation 
in research. When Cultural Ambassadors are involved in 
studies, minority participation averages between 37 and 
65 percent. When they’re not involved, minority par-
ticipation drops to between 2 and 3 percent. Beyond that, 
the level of trust between the community and the School 
of Medicine has increased—Cultural Ambassadors now 
encourage members of their community to participate in 
research, helping to dispel some of the myths that they 
themselves had believed just a few years ago.
time, trial, and error
Long before the Cultural Ambassadors program, School 
of Medicine researchers had been engaging with 
residents, involving them in what is now known as 
community-based participatory research (CBPR). For 
more than 40 years, Yale was a site of the RWJF Clinical 
Scholars Program, a two-year fellowship that includes 
community-partnered research. This program is being 
phased out in 2017, but Yale and three other institutions 
have established their own version of the program, the 
National Clinician Scholars Program (NCSP). 
Under the RWJF program, a 30-member commu-
nity advisory steering committee comprising leaders 
and representatives from New Haven community orga-
nizations, the City of New Haven, community health 
clinics, and Yale faculty, meets every month to estab-
lish research priorities, work with researchers on study 
design, and build community-academic partnerships. 
“The relationship has been one of evolution and a 
learning exchange,” says Natasha Ray, M.S., core 
services manager of New Haven Healthy Start at the 
Community Foundation for Greater New Haven. She 
co-chairs the committee with Marcella Nunez-Smith, 
M.D., M.H.S. ’06, associate professor of medicine and 
of epidemiology, core faculty member of the NCSP, and 
a former RWJF Clinical Scholar.
The value of this collaboration became apparent about 
the time of Hurricane Irene in 2011, which coincided with 
an upswing in gun violence in New Haven. It occurred 
to Barbara Tinney, M.S.W., co-chair of the steering com-
mittee, and Nurit Harari, M.D., FW ’13, then an RWJF 
Clinical Scholar, that the response to natural disasters 
might also work for gun violence. “That was transfor-
mative,” says Emily Wang, M.D., associate professor of 
medicine (general medicine), “to think of gun violence as 
something that can be prepared for and mitigated.”
Beginning in 2014, Wang, a second pair of RWJF 
scholars, and Maurice Williams, a YCCI staff mem-
ber, trained 17 community members in New Haven’s 
Newhallville and West River neighborhoods to gather 
data from more than 150 neighbors. They asked not only 
about exposure to gun violence but also about whether 
their neighbors prepared for it. Most had heard a gunshot, 
a third had witnessed a shooting, and nearly 60 percent 
had lost a friend or family member in a shooting. Most 
of their neighbors had established a family plan that 
included discussing gun violence with their children or 
buying burial insurance. “Unless you include community 
members from beginning to end and honor their skills 
and expertise, you won’t get to the right questions,” says 
Wang, who is a core faculty member of the NCSP. “We 
would never have thought of including questions about 
preparedness without their input.”
The study found a connection between a commu-
nity’s ability to leverage social ties and rebound from 
adversity, and lower exposure to gun violence. The 
next set of scholars, Alicia Agnoli, M.D., M.P.H., and 
Anita Arora, M.D., M.B.A., is taking the research a step 
further, trying to strengthen bonds among community 
members, over half of whom knew none or a few of 
their neighbors. Through trial and error, they settled 
on a monthly intervention—Game Day—the brainchild 
of Ann Greene, a community research liaison with the 
NCSP and a West River resident, and Victoria Spell, 
also a community resident. 
At the Game Day held in March at the Barnard 
Environmental Studies Magnet School on Derby 
Avenue, about 50 West River residents ranging from 
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follow up with health care providers. Often, he found, 
they were discharged too late to be admitted to a shelter. 
When Greysen’s fellowship ended, Kelly M. Doran, M.D., 
M.H.S. ’13, now at New York University School of 
Medicine, continued the project, gathering data from 
the hospital to determine how to improve health care for 
homeless patients after discharge. 
As of 2013, Columbus House has a Medical Respite 
Program—the first in Connecticut. Up to 12 clients can 
recuperate from surgery, an illness, or an injury in a 
private room while receiving skilled nursing care from 
home care organizations. They also get help connecting 
to community services, transportation to appointments, 
and assistance with finding housing. 
Medical respite is a new field. There are only about 
70 programs in the country, with differing models of 
care. Alison Cunningham, chief executive officer of 
Columbus House, was at first skeptical, but she offered 
the program unused space on the shelter’s third floor. 
Before the program started, hospital readmission rates 
for homeless people in New Haven were 51 percent. 
Today, they’re down to 17 percent, and only 4 percent 
of respite patients return to the streets. The program 
also saves Medicaid about $12,000 per patient. “It has 
opened our eyes to a different way of thinking of the 
relationship between housing and health care, and how 
important it is for people’s health for them to be stably 
housed,” says Cunningham. The program, she added, 
would not exist without the RWJF Scholars.
Ensuring that health care solutions meet the most 
pressing needs of the community is one of the goals 
of community-based research. At a recent Cultural 
Ambassadors meeting, Paul Taheri, M.D., M.B.A., deputy 
dean for clinical affairs and CEO of Yale Medicine, sought 
the group’s input on possible ways to reduce the burden 
of chronic diseases in the community. The conversation 
was a first step in thinking about what kinds of studies 
to design, the type of data that would need to be col-
lected, and how the community could help. Ambassadors 
asked questions and offered suggestions about how to 
delve deeper into New Haven’s health issues. Taheri plans 
on meeting with the group again during the process of 
designing a research study. Says Junta’s Trevino: “Our 
partnership has shown me that our needs matter and our 
voices are heard.” /yale medicine
Jill Max is a senior communications officer at the School of Medicine.
toddlers to grandparents gathered to play games, shoot 
baskets, and socialize over pizza. Intended to reinforce 
the notion that West River is a safe neighborhood in 
which to socialize, it was an opportunity for them to 
get to know one another on a deeper level. “We don’t 
have a lot of places for children and families,” says 
Joseph Vidro, who walked to Barnard in the freezing 
weather with his 13-year-old son. “We get to know 
each other as a village so we can help each other out. 
It’s great that the community comes together.” Greene 
has noticed a change in the way her neighbors interact. 
“I found that we have much more intimate and interest-
ing conversations than we ever did when we just ran 
into each other on the sidewalk,” she says.
Along the same lines, researchers looked into which 
skills residents possess and which they’d like to learn. 
“In neighborhoods like mine,” says Greene, “people 
don’t realize how much human gold there is, how 
many talents, because they’re not necessarily tied to 
a degree or high-status occupation.” Like Game Day, 
Skills Day brings people together and encourages 
neighbors to help each other. Follow-up research will 
determine whether these activities have increased 
resilience and strengthened bonds. In another arm of 
the research, Wang and Andrew Papachristos, Ph.D., 
associate professor of sociology, are using police data 
on gun violence to identify pockets of residents of 
high-risk areas who have never been involved in gun 
violence. The idea is to identify those characteristics 
that protect neighborhoods from violence and figure 
out how to apply that knowledge elsewhere.
a widespread problem
While gun violence is often concentrated in certain 
areas, homelessness remains an issue in New Haven—in 
2016, more than 600 people were living in emergency 
shelters, transitional housing, or on the streets. In 2010, 
RWJF Scholar S. Ryan Greysen, M.D., M.H.S. ’11, M.A., 
now at the University of Pennsylvania Perelman School 
of Medicine, wondered how the homeless people he saw 
in the emergency department made the transition from 
the hospital to the shelter. Working with the Columbus 
House shelter, he surveyed homeless clients and found 
that they often left the hospital without a clear under-
standing of how to obtain prescription medications or 
23Spring 2017
Last autumn, on November 17 at Café Med, the crowd 
at the School of Medicine’s 24th Annual Hunger and 
Homelessness Auction grew quiet as Kim Hart, a 
55-year-old lifelong New Haven resident, came to 
the microphone to provide a firsthand look at what it 
means not to have enough to eat. Hart, who lives in the 
Beaver Hill section of the city, took her listeners back 
to 2011, a harrowing moment when the only things left 
in the cupboard were “a two-pack of ramen noodles, 
a half loaf of bread, and some peanut butter and jelly.” 
She used what she had to feed her then-11-year-old son.
“I was hungry,” she told the audience, “but I didn’t 
eat until he’d had enough.”
The modest meal over, the boy looked up and said 
that while he was grateful—he knew other people had 
less—he wished they could have meat. “As a mom, this 
broke my heart—he shouldn’t have to live like that,” 
Hart said quietly, tearing up at the memory.
There’s a photograph from that time—a snapshot of 
a youngster with sad and haunting eyes—that was part 
of a recent exhibit called Witnesses to Hunger CT at the 
Legislative Office Building in Hartford. The program 
featured images and stories from 15 state residents, each 
among the one in seven Connecticut residents who, 
according to End Hunger CT, regularly don’t get enough 
to eat. Six years ago, Hart and her son became statistics.
“We were comfortable,” she explained in an inter-
view with Yale Medicine. “My husband’s disability 
check paid the rent, we had food stamps, and I was 
working part-time as a telemarketer. We didn’t have a 
lot, but we had enough.”
In 2011, Hart’s husband passed away suddenly, 
and making ends meet proved a struggle without his 
income. Later that year Hart’s job ended when the tele-
marketing company moved to Indiana.
With a meager unemployment check the only 
money coming in, Hart’s life became endless treks to 
the area’s food pantries. “Once you dig yourself in, it 
becomes so hard to get out,” she said. But Kim Hart is 
nothing if not a consummate optimist, and the first 
thing she did was confront her diet. “I became edu-
cated about food, and the more I learned, the angrier I 
became,” she said. “I realized that the food I should be 
eating and feeding my son was not what I could afford.”
At the annual Hunger & Homelessness Auction, Yale 
students hear firsthand what it’s like to be hungry.
by bruce fellman
A witness  
to hunger
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The organic aisles in the local supermarket might 
have been out of reach, but Hart learned how to make 
healthier choices with what was available and to cook 
in a healthier way. “I don’t fry anything anymore, and 
while it took a while for my son to accept this, we now 
both know it’s for our own good and not to punish 
us. Whole-wheat pasta, rye and pumpernickel bread, 
a baked sweet potato—the darker the food, the more 
nutritious,” she declared. “I wasn’t taught this growing 
up, but now I embrace this.”
Hart soon learned to visit local farmers’ markets 
where, she discovered, she could double the pur-
chasing power of her SNAP benefits and buy fresh 
fruits and vegetables. (SNAP stands for Supplemental 
Nutrition Assistance Program, which replaced what 
were once called food stamps.) “The fact that I could 
get two pounds of collard greens for $1.39 instead of one 
pound … it was a big secret and not advertised, but since  
I learned this trick, I tell everyone I know,” Hart said.
She has also turned this ongoing education into 
political activism. She was appointed to the New Haven 
Food Policy Council, the city government’s volunteer 
advisory group that, according to its mission statement, 
works to “build a food system that nourishes all people 
in a just and sustainable manner.”
Hart is involved in such council efforts as a partner-
ship with the American Heart Association’s ANCHOR 
program to help improve the already-existing food 
pantries. “We’re telling people about the importance of 
good eating and heart health—how it all ties together,” 
she said. “Everything starts with knowledge.”
Hart is also working on programs to end food inse-
curity, including a proposal to start a supper program 
in area schools. “A child in need might eat lunch at 
school, but there may be nothing to eat at home,” she 
said, counseling physicians to ask their patients about 
food availability and hunger issues. “You can’t learn 
anything if you’re hungry—in the long run, ignorance 
is very expensive.”
Despite the seeming intractability of the problems 
she continues to face, Hart remains upbeat. “I am a 
woman of faith,” she declared. “Hope and faith keep 
me going.” /yale medicine
















Kim Hart knows what it is to be 
hungry. After her husband died 
and she lost her job, she and her 
young son relied on unemploy-
ment benefits, food stamps, 
and food pantries. She is now 
an advocate and activist, and 
serves on the New Haven Food 
Policy Council.
How the School of Medicine and community  
partners work together for a healthier New Haven.
by jeanna canapari 
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Stacy Downer once worked on 
Chapel Street at a check cash-
ing business where customers 
also paid their bills. She helped 
her customers make budgets 
and plan expenses, skills 
she uses in her work at the 
New Haven Mental Health 
Outreach for MotherS, which 
connects mothers to mental 
health services so they can 
combat depression.
Mental health, better schools, and the trauma of violence
from her window at a downtown check cashing 
business just off the New Haven Green, Stacy Downer 
had a front-row seat to her community. Through her 
interactions with her customers, she saw how they 
struggled and how hard they worked to get by. “I 
started to see that things were not right,” she recalls. 
She could predict when the people who were selling 
the food, clothes, and shoes she bought on the street 
outside would come in each month to use the busi-
ness’ bill paying service. “They would pay $50 here 
and $50 there, just so they could have $300 in their 
pocket for the month,” Downer observed. “They 
needed help.
 “I started learning little things that would help 
me keep money in my pocket, and not always be so 
stressed out,” she says. “I started helping my custom-
ers do the same thing. When they came in, they would 
give me all their bills, and I started writing budgets 
for them. Sometimes right there at the window.” Her 
sharp financial sense led to a promotion to manager, 
but a downturn in the economy shuttered the check 
cashing business, and Downer lost her job.
Shortly after, she was recruited by the New Haven 
Mental Health Outreach for MotherS, or MOMS, 
Partnership, which links eight government and non-
profit agencies, including the School of Medicine. 
Housed at the Department of Psychiatry and the Yale 
Child Study Center, the MOMS Partnership connects 
mothers to mental health services to help them com-
bat depression.
MOMS is one of many community partnerships that 
allow the School of Medicine to engage with the New 
Haven community. Some, like MOMS, help women in 
need; others, like the Yale Child Study Center’s Comer 
School Development Program, help children succeed 
in the public schools. All the School of Medicine’s 
partnerships link Yale experts with people in the 
community poised to help others: another, the Child 
Development-Community Policing Program, partners 
New Haven police officers and Yale clinicians, who 
arrive together at crime scenes to counsel children 
who have witnessed violence. These partnerships loop 
in a variety of stakeholders to work above and beyond 
the capacities of traditional institutions, and use inno-
vative approaches to fill gaps in services. 
an ambassador for mental health
“We have taken many approaches to address maternal 
depression in the last decade or more in New Haven, 
and those approaches weren’t yielding tremendous 
results in terms of changing outcomes for families,” 
says Megan V. Smith, M.P.H. ’00, Dr.PH., principal 
investigator and director of the MOMS Partnership. 
“The partnership started out of a general recognition 
that there was a need for innovation in the area of 
maternal depression and maternal mental health.”
One of those innovations is the position of 
Community Mental Health Ambassador. Downer, the 
former check cashing manager, is one of 10 ambassa-
dors, all mothers from the New Haven community who 
are trained to work side by side with Yale clinicians to 
provide counseling and other services, including job 
training and connections with housing. Ambassadors 
are employed by Yale, as well as by the Clifford Beers 
Clinic and the New Haven Health Department, both 
MOMS Partnership members. “We employ mothers 
from New Haven who might have had experience in 
a nail salon, or a hair salon, or who have worked in 
a customer service profession,” says Smith. The job 
builds on these women’s natural empathy and lead-
ership skills from previous jobs, like Downer’s work 
helping customers and neighbors with budgeting. 
Ambassadors teach mothers vital skills and strate-
gies to manage their stress and depression, find better 
jobs, and become more effective, less harried parents. 
They have also been trained to employ such mental 
health strategies as cognitive behavioral therapy, or 
CBT, one of the most efficacious treatments for depres-
sion, according to Smith. “In CBT, they give mothers 
concrete examples of the skills we are trying to teach, 
so they can apply skills that we teach to experiences 
that mothers may actually have,” says Smith. 
When she speaks to women, Downer shares her 
own experiences raising her children in downtown 
New Haven. “Before I got the job at the check cashing 
place, I was homeless. I was living in a shelter,  
and I was pregnant,” she says. “And there was no 
help.” Sharing her own story, she says, makes her 
more effective. 
On a winter evening, Downer and a colleague 
attended a community event at the Wilson Branch 
of the New Haven Public Library in the Hill neigh-
borhood, a few blocks from the School of Medicine 
campus. The room around them buzzed with activity: 
Volunteers helped people prepare tax returns; children 
ran around; women held a dance class. And a woman 
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approached Downer’s table to find out more about 
MOMS Partnership services. 
Depression is a severe problem for women in dis-
tressed communities like the Hill. According to a 2016 
report published by the MOMS Partnership, 71 percent 
of women interviewed in New Haven reported needing 
help managing sadness. In the Hill neighborhood alone, 
87 percent of mothers felt they had poor emotional 
health. But many fear asking for help. “One of the bar-
riers that prevents women from seeking mental health 
services is that they are afraid their children may be 
removed from their care,” says Smith. “That’s a real 
fear.” There is also a stigma in the community, Smith 
says, about asking for mental health help.
To remove some of that stigma, MOMS brings their 
services to places where women may gather, like 
community events at the library. The program also 
runs five “hubs” around New Haven at such places 
as the Stop and Shop on Whalley Avenue and a pub-
lic school in West Rock. At these dedicated centers 
for mental health and job training services, the 
Partnership offers classes on parenting, stress man-
agement, and financial health.
So many programs, Downer says, come and go from 
New Haven without having made any real impact. “Over 
the years, they have broken down the resolve of moms 
in the community. They are not trusted,” she says. “I say 
to the moms, ‘I want you to understand that someone is 
out here, and they are here for the long haul.’ ”
a partnership that has endured
Starting in the 1960s, James P. Comer, M.D., M.P.H., 
the Maurice Falk Professor of Child Psychiatry in the 
Child Study Center, saw that cultural institutions that 
had sustained black families were eroding and putting 
children at risk. 
“There was a decline in the power of the family and 
in the church community,” he recalls. “The old corner 
drugstore gave way to Walgreen’s. The policeman on 
the beat was no longer on the beat, and he was no lon-
ger a friend of your family.”
While some families in the face of racism and pov-
erty were able to create home cultures that protected 
children and helped them thrive, not all could. Many 
black children were underperforming in school and get-
ting into trouble. These problems required a new way of 
thinking that challenged the way institutions connected 
with their communities. “The schools had that potential 
that nobody else had,” Comer says. “We needed institu-
tions to change so that they became part of the family, 
and the family became part of the schools.”
Comer saw that students from poor areas were not 
lost causes, as public schools had assumed, but had 
what it takes to be successful in school. What they 
lacked was the preparation that would move them into 
readiness. Schools, Comer realized, needed to address 
six developmental pathways: social-interactive, psycho-
emotional, ethical, cognitive, linguistic, and physical. 
The solution was a community partnership—the Comer 
  Gail DeBlasio, Brennan-Rogers School Principal
 “Our test scores are going up  
slowly but steadily. We still have kids  
  in crisis, but we are not going backward.  
 We are moving forward. 
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School Development Program (SDP), a collaboration 
between the Yale Child Study Center and the public 
schools of New Haven—that pioneered the idea that 
children should be taught according to the principles of 
child development. 
During her 25 years in New Haven schools as a 
teacher and magnet resource coach, and now as a 
principal of the Brennan-Rogers School, Gail DeBlasio 
has seen how important it is to understand the tenets 
of child development to reach children, particularly 
those who are vulnerable. “I think sometimes we for-
get as adults that we are better able to compartmen-
talize our hurt, but as kids, those wounds fester, and 
they erupt in the classroom and come out as difficult 
behaviors. We assume it’s a child misbehaving, and not 
a child in crisis, or a child who has had enough.”
DeBlasio is applying Comer principles at Brennan-
Rogers, a low-performing Pre-K through eighth grade 
magnet school in New Haven’s West Rock neighbor-
hood, where 20 percent of its more than 500 students 
require special education services. Children often have 
water bottles at their desks to support their physical 
development. They take “Brain Breaks” and get up 
to toss a ball around while shouting out math facts. 
During daily morning meetings, students talk about 
problems with other children, or stresses from outside 
school that might affect their learning. Building from 
those discussions, students are then asked to medi-
ate disputes between fellow students. Those meet-
ings “brought SDP into the classroom by dealing with 
children’s psychological and ethical pathways,” says 
DeBlasio. “Learning how to disagree in an agreeable 
manner, being able to identify and express what’s 
bothering them, and learning how to articulate that 
properly—those are all skills that we take for granted 
that kids have, but they have to be built.”
As in all Comer schools, Brennan-Rogers has a 
School Planning and Management Team of administra-
tors, teachers, support staff, and parents to guide the 
core goals of the school. Comer schools also have two 
community-centered teams: The Student and Staff 
Support Team plans interventions around students 
who are not performing successfully in the classroom. 
The Parent Team, which is more inclusive than a tra-
ditional parent-teacher organization, involves any 
parent who wishes to develop activities that enrich the 
school’s social and academic programs. 
“The whole notion of bringing the community into 
the school,” says DeBlasio, “really started with the 
Comer program.” That notion extends to classrooms, 
where students have a say in how classrooms are run: 
At the beginning of each school year, students draft 
classroom rules. “They are invariably tougher than I 
would have been,” DeBlasio laughs. 
In 1968, Comer and his team initiated the SDP in the 
two lowest-income and lowest-achieving elementary 
schools in New Haven, where 70 percent of students’ 
families were receiving federal assistance. After three 
years, Comer said, the climate the program aimed to 
create had taken hold; after seven years, attendance 
improved, and the number of behavioral problems 
dropped. By 1979, Comer wrote in a 1988 Scientific 
American article, fourth-grade students were up 
to grade level, and by 1984, fourth-graders in both 
schools ranked third and fourth in New Haven on the 
Iowa Test of Basic Skills. 
 The Comer model has since been implemented in 
more than 1,000 schools in 26 states, the District of 
Columbia, Trinidad and Tobago, South Africa, England, 
and Ireland. Twenty-eight New Haven schools still use 
the Comer model, and most of the district’s 46 schools 
have had some training with the program.
At Brennan-Rogers, DeBlasio has seen incremen-
tal change thanks to the Comer principles. “Our test 
scores are going up slowly but steadily,” she says. “We 
still have kids in crisis,” she says, “but we are not going 
backward. We are moving forward.” 
helping children cope with violence
When children are exposed to violence, a quick 
response is of the essence: it helps reduce the damag-
ing, lasting effects of witnessing violence and allows 
the recovery process to begin.
As first on the scene, police officers may also be the 
first to establish the order and safety that is the first 
step to a child’s recovery. The officers are there well 
before mental health and social services professionals 
can provide crucial early intervention. 
Twenty-five years ago, Steven Marans, M.S.W., Ph.D., 
Harris Professor in the Child Study Center, saw an 
opportunity to connect clinicians and police officers so 
that children get the help they need. In 1991, he founded 
the Child Development-Community Policing (CD-CP) 
program, a partnership between the Yale Child Study 
Center and the New Haven Police Department. The 
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program is housed in the Childhood Violent Trauma 
Center (CVTC) led by Marans. The program’s three goals 
are to keep children and families safe, provide a sense of 
security, and offer services to help with recovery.
Children who witness or experience violence are at 
risk of anxiety disorders, post-traumatic stress disor-
der (PTSD), alcohol and drug abuse as adolescents, and 
antisocial behavior. Later in life they may themselves 
inflict violence on others. “Instead of sitting in our 
consulting rooms way down the road when kids are 
already struggling, we reached out to the police,” says 
Marans. Police, he adds “recognized that they were not 
going to arrest their way out of the cycle of violence. 
And they reached out to us.”
Under the CD-CP, clinicians from the Child Study 
Center respond with police to emergencies that involve 
children who are victims or witnesses to violence or 
disaster. Clinicians can help police discern signs of 
trauma that might not be obvious. “The blank stare of a 
child doesn’t mean that they are OK,” says Marans, “but 
that they are very much not OK.” When police recognize 
that children need help, they may use breathing exercises 
and other therapeutic techniques to alleviate anxiety. 
Two-person teams of police officers and clinicians 
follow up with visits to children and their families at 
their homes in the days following traumatic events. 
The teams look for symptoms of traumatic stress, and 
then invite the children and families to the program’s 
clinic for an intervention. The Child and Family 
Traumatic Stress Intervention (CFTSI), developed at 
the Child Study Center, increases communication and 
family support with the aim of decreasing the effects 
of post-traumatic stress in the peri-traumatic phases, 
within 30-45 days of a traumatic event or abuse.
A 2009 study at Yale found that children who partici-
pated in CFTSI were 65 percent less likely to experience 
symptoms of full PTSD after three months compared to 
children who did not undergo the intervention. CFTSI 
training is offered to other agencies beyond Yale that 
aim to help children affected by violence, and is now 
used by clinicians around the country. 
In the past 25 years, the program has extended its 
reach to other communities not only around the nation 
but around the world. Through a partnership with the 
International Association of Chiefs of Police, CD-CP 
provides law enforcement officers with materials and 
resources to promote the best practices and methods 
that the program has developed through their long 
experience in New Haven. The CD-CP also offers a 
round-the-clock consultation service in which clini-
cians provide guidance over the phone to police offi-
cers at the scenes of emergencies. 
For police officers and clinicians, learning to walk 
in each other’s shoes has been invaluable, most of all to 
the families that they are now able to help. “When one 
gets to learn firsthand about the experience of others,” 
Marans says, “It changes the way you look at the world.”
Community partners exemplify the notion that 
what is necessary to fix a community is already present 
within it. James Comer looks to the present shortage 
of primary care physicians in the United States as an 
example. “We are going to have a huge shortage of doc-
tors because people say they can’t import them,” he 
says. “Well, what do you mean, you can’t import them? 
They’re here, they’re walking the street, they’re in your 
schools right now. You just mishandle the way you 
develop them.” 
“They did a good thing harvesting us from the com-
munity,” says Stacy Downer. “I’m going to be passion-
ate. This is my community. I love New Haven like I love 
my kids. I grew up here, and I intend for my kids to 
grow up here. Of course I am going to advocate for this 
agency that I feel I can trust, so I put my best foot for-
ward.” /yale medicine


















Bio Haven: Research nurtures a local  
bioscience industry.
by steve hamm
How Yale  
and New 




The Mill River in New Hav-
en’s East Rock neighborhood 
is a favorite spot for Craig 
Crews. On his morning jogs 
there, he tackles problems 
from the lab—turning ideas 
into therapies. As a scientist 
and entrepreneur, he strad-
dles the worlds of discovery 
and business that are at the 
heart of the city’s plans for 
economic development.
How Yale and New Haven are building a future together
craig crews, ph.d., does some of his best think-
ing during early morning jogs along New Haven’s Mill 
River. The two-mile run along the river that meanders 
through woods and marshes near his home in the East 
Rock neighborhood allows Crews’ mind to wander—
and to fix on new ideas.
Those ideas feed his work at his lab on Yale’s Science 
Hill, where his team of 18 researchers is inventing sci-
ence at the intersection of biology and chemistry. Their 
goal is to transform medicine with a radically new 
approach to treating disease. 
His morning runs also take him to the earliest days 
of industry in New Haven, past the Whitney Armory 
where, in the late 1700s, Eli Whitney produced one 
of the seminal ideas of the industrial revolution—the 
notion that things could be manufactured more reli-
ably and efficiently by using interchangeable parts. 
Crews has always admired the pioneers of industries, 
including Whitney and Thomas Edison, and he’s proud 
that his hometown has been at the forefront of one 
industry after another, from guns and clocks to horse 
carriages and hardware. “Here in New Haven there’s a 
long history of practical innovation—embracing tech-
nology and having an impact,” he says.
In fact, Crews is cut from the same cloth as Whitney 
and Edison. He is not only a leading medical science 
researcher, but also an entrepreneur. Arvinas, the 
company he started four years ago, uses ideas from his 
lab to develop therapies for treating cancer. Crews also 
helps other Yale researchers—and their inventions—
make the journey from the lab to the marketplace. 
The manufacturing industries of New Haven’s past have 
faded or disappeared, and today’s primary drivers of the 
local economy are Yale University and Yale New Haven 
Hospital. Together, they employ more than 24,000 people. 
But for years, leaders at Yale and the city have encouraged 
the rise of a new industry, biotech, to stimulate job growth 
and economic dynamism. And, since medical science 
research is the essential ingredient for fostering a biotech 
industry, and health care is essential for a high quality of 
life, they see Yale School of Medicine at the center of things. 
“We want to create a seamless economy of health care, and 
over a 60-year period the city has had a series of success-
ful strategic plans to accomplish this, to link innovation 
to commerce, and the city and the medical campus to 
downtown,” says Matthew Nemerson, M.P.P.M. ’81, New 
Haven’s economic development administrator who started 
his career in the city in 1983 as the first head of develop-
ment for Science Park.
New Haven’s biotech community has seen fits and 
starts, but today it is achieving critical mass. Upwards 
of 50 biotech and medical device companies employ 
more than 5,000 people in greater New Haven. Venture 
capital firms and large pharmaceutical companies 
have invested more than $700 million in startups—and 
these startups have attracted another $5 billion in 
equity investments. Yale, the state, and the city have 
established programs aimed at helping student and 
faculty inventors become entrepreneurs. And New 
Haven itself has become a more attractive place for 
young scientists and engineers to live. More than 2,000 
housing units have been built or renovated in or near 
the downtown area in the past decade, so people can 
walk to the city’s abundant museums, theaters, pubs, 
cafés, and restaurants.
Optimism is on the rise. More than 300 entrepreneurs, 
faculty members, students, investors, real estate develop-
ers, government officials, and Yale administrators turned 
out for the Dec. 13 holiday party of Connecticut United 
for Research Excellence (CURE), the bioscience industry’s 
advocacy group. CURE president Susan Froshauer, Ph.D., 
FW ’89, an entrepreneur-in-residence at Yale’s Office of 
Cooperative Research where she’s working on two Yale 
startups, later said that “the energy was the best I’ve seen. 
People were effervescent with hope.”
Challenges remain, however. Growing biotech com-
panies have insatiable appetites for laboratory space. 
Tweed New Haven Airport needs an upgrade to make it 
easier for venture capitalists and pharma company exec-
utives to get to the city. New Haven still has an image as a 
crime-ridden city, a reputation that could deter scientists 
from moving here. And then there’s government funding. 
If politics and budget pressures reduce funding of basic 
research at Yale, the biotech engine will sputter.
For New Haven’s biotech industry to grow and 
prosper, more collaboration is required involving Yale, 
the state, and city governments, real estate develop-
ers, local schools, venture capitalists, and educational 
leaders, says William Ginsberg, president of the Greater 
New Haven Foundation and a member of the board of 
Yale New Haven Hospital. “I’d like to see a very clear 
leadership strategy for the entire community,” says 
Ginsberg, who first envisioned a biotech industry 
emerging here when he was the city’s economic devel-
opment director in the 1980s.
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Nothing embodies the coming of age of New Haven’s 
biotech industry more than the shiny new 14-story tower 
at 100 College Street with the name “Alexion” embla-
zoned across the front. Former faculty member Leonard 
Bell, M.D. ’84, launched Alexion Pharmaceuticals in 
Science Park 25 years ago—based on his research at Yale. 
The company develops drugs for combating very rare 
diseases. He left the university to become the company’s 
CEO, and only recently retired. Alexion quit New Haven 
for Cheshire, a suburb 17 miles to the north, 15 years 
ago, but when it needed to grow again and was lured by 
government incentives, it returned to its roots in 2016. 
Approximately 1,000 people work at the global head-
quarters in New Haven and Alexion expects to continue 
to grow in Connecticut. “New Haven is a changed place,” 
Bell explains. “And we believe our success and our pres-
ence here will be great for Yale, for the community, and 
for people who want to locate here.”
The building at 100 College Street spans Route 34, 
so it bridges New Haven’s downtown and the medi-
cal school and hospital. The crossroads location brings 
new attention to the shared interests that bind town 
and gown. No one is more aware of that interplay 
than Robert J. Alpern, M.D., dean of the School of 
Medicine and Ensign Professor of Medicine. And while 
he believes that the most important thing the medical 
school can provide for New Haven is outstanding med-
ical care, he’s also attuned to the benefits that come 
from research funneling into local startups.
But rather than abandoning their labs to become 
entrepreneurs, Alpern says it’s preferable to stay in 
the lab and advise the biotech companies that license 
inventions and take them to market.
Craig Crews provides a model for that approach. 
Like 100 College Street, Crews is a bridge between the 
university and the business community. He spans the 
two worlds, but he still lives in the lab.
focusing on impact
For bioscience innovations to have a major impact on 
society, there are two essential elements: great ideas 
and great ambitions. Crews has both.
He joined the Yale faculty in 1995 at a time when deep 
explorations of the interface between chemistry and biol-
ogy were just beginning. (He’s now the Lewis B. Cullman 
Professor of Molecular, Cellular, and Developmental 
Biology, with appointments in the departments of chem-
istry and pharmacology.) Soon after he established his 
lab, Crews hit on the big idea that has shaped much of the 
work since then. At the time, scientists were exploring 
the use of chemicals from nature as models for develop-
ing cancer-killing therapies. Crews and the team studied 
natural compounds, and armed with those findings, 
tweaked the human body’s ubiquitin/protease system 
to attack diseases at the cellular level. They created syn-
thetic compounds that mimic nature, searching for those 
that would block harmful proteins or dispose of them 
with minimal side effects. And they struck gold.
The science harnesses the human body’s system for 
routinely targeting damaged proteins and breaking 
them down into small peptides and then into amino 
acids for reuse. Crews and his team developed a technol-
ogy they call Proteolysis-Targeting Chimeras (PROTAC), 
which tags harmful proteins so they will be degraded 
by the proteasome—the body’s quality control system. 
Crews calls this a “seek-and-destroy mission.”
These days, Crews says, the most exciting project 
at the lab is an effort to use PROTAC technology to 
degrade kinases, enzymes that play a key role in cell 
growth and metabolism. PROTAC uses the characteris-
tics of kinases to remove disease-causing proteins. As a 
result, PROTAC-based drugs may well outperform cur-
rent drugs for attacking a wide range of diseases.
On a Monday morning in March, Crews took his seat 
at the head of a table for his lab’s weekly meeting in a 
conference room on the 12th floor of Kline Biology Tower. 
About 20 students and researchers sat on chairs around 
the periphery as Saul Jaime-Figueroa, Ph.D., a research 
associate scientist, discussed the ability of a family of 
PROTACS to degrade kinases. Crews peppered him with 
friendly but probing questions. Finally, pleased with 
the team’s progress, he reminded them of a core belief: 
“When you do anything with commercial potential, we 
owe it to you guys and to Yale to file for patents.”
building companies
In popular mythology, bright young scientists with 
big ideas raise capital, launch startups, and become 
the CEO. That’s Leonard Bell’s story. And today, Bell 
and Alexion provide inspiration for other Yale medical 
researchers: become an entrepreneur, run a company, 
and maybe become rich in the process. But because the 
skills and mindset of research and business are so dif-
ferent, it’s the rare scientist who can make the transi-
tion to running a successful startup company.
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How Yale and New Haven are building a future together
Fortunately, there are alternative paths for 
researchers who want to shepherd their discover-
ies from the lab to the clinic. For one thing, they can 
launch companies, hand them over to professional 
managers, and take part-time science advisory roles. 
That was Crews’ route, first with a company called 
Proteolix, and now with Arvinas. 
In recent years, the business model for develop-
ing new therapies has undergone a dramatic upheaval. 
Previously, most large pharmaceutical firms typically 
developed drugs from scratch, guided them through reg-
ulatory approvals, and took them to market. Now, these 
companies increasingly leave much of the exploratory 
work to research-based startups, then buy companies or 
their intellectual property after ensuring that the drugs 
have a good chance of passing muster with regulators.
The industry shift makes the relationships between 
academic inventors and startups even more important. 
As Arvinas’ chief scientific advisor, Crews participates 
in a 90-minute review every Tuesday morning, where 
he gives feedback on new directions for research. 
(Arvinas, headquartered in Science Park at Yale, is a 
10-minute walk from his lab.) Arvinas has two thera-
pies that it hopes to put into clinical trials next year—
oral treatments for breast and prostate cancer—but the 
company is now looking at other diseases.
Crews is also the company’s “storyteller,” accord-
ing to Sean Cassidy, Arvinas’ chief financial officer. At 
a biotech industry conference in January 2017, Crews 
explained PROTAC to potential business partners in 
speed-dating briefings that lasted from morning until 
night. According to John Houston, Arvinas’ president 
of R&D, Crews’ presentations were instrumental in 
piquing the interest of several large companies, which 
are now talking to Arvinas about forging partnerships.
The company already has drug development deals 
with two industry giants, Genentech and Merck, which 
have committed to investing more than $700 million. 
Those partnerships prompted Arvinas to boost hiring, 
and the company considered leaving New Haven. “We 
were busting at the seams,” says CFO Cassidy. Instead, 
they expanded into adjacent space in Science Park.
Another alternative to the quit-the-university route 
for researchers is taking advisory roles with one or 
more startups. Many biotech companies have advisory 
boards, but another inventor with close ties to Yale has 
gone a step further by including academic researchers 
as key players in the companies he starts. 
Jonathan Rothberg, Ph.D. ’91, professor (adjunct) 
of genetics, was one of the pioneers of next-generation 
gene sequencing. Last year, Rothberg received the 
National Medal of Technology and Innovation from 
President Obama for this achievement. At his Guilford-
based startup incubator, 4Catalyzer, each of his four 
new companies leverages genetics and advances in 
artificial intelligence to develop drug therapies and 
medical devices. And each of them benefits from a sci-
entific advisory council that includes faculty from Yale 
and other elite institutions. The researchers and clini-
cians help identify new therapies, help design them, 
and in some cases, help test them in clinical trials.
One of the new companies, LAM Therapeutics, has 
two drugs in clinical trials. The company was co-
founded by Yale geneticist Tian Xu, Ph.D., the C.N.H. 
Long Professor of Genetics and professor of neurosci-
ence at Yale, and is based on technologies invented in 
his lab. Xu plays an active role as an advisor.
a support system for entrepreneurs
Qin Yan, Ph.D., associate professor of pathology and 
director of the pathology department’s epigenetics 
program, dreams of following in Crews’ footsteps and 
starting a company to take his ideas into clinical prac-
tice. Yan knows biology, but he doesn’t know how to 
be an entrepreneur. Fortunately, he’s getting a lot of 
support from Yale—and mentorship from Crews—to 
help him find his way.
Several years ago the university, with financial 
backing from the state, established the Yale Center for 
Molecular Discovery on its West Campus. There, a dozen 
chemists, biologists, and computer scientists test com-
pounds developed by Yale and University of Connecticut 
researchers, for their potential as therapies. The idea is 
that by using this process, researchers can more quickly 
identify valuable molecules. That way, the researchers 
can focus on their work and gather the evidence they 
need to win backing from venture capitalists.
Crews, who was involved in setting up the center, 
saw that such would-be entrepreneurs as Yan needed 
more help, so last year he created a companion pro-
gram, called PITCH, to guide faculty members toward 
success in biotech. Advisors help researchers draft 
business plans and craft their pitches to investors. 
Yan says PITCH has given him confidence. “If all goes 
well,” says Yan, “we hope to form the company next year.” 
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The Center for Molecular Discovery, the PITCH pro-
gram, and the Blavatnik Fund for Innovation at Yale, a 
$10 million grant from the Blavatnik Family Foundation 
aimed at fostering entrepreneurship in the life sciences, 
are three elements of a broader biotech agenda shared 
by Yale, the state, and the city. Some real estate devel-
opers are deeply involved, too. For instance, Winstanley 
Enterprises not only developed 100 College Street but 
also contributed $100,000 toward a new city partner-
ship with Southern Connecticut State University to 
guide more residents into bioscience careers. 
For Yale, the focus on technology transfer and local 
entrepreneurship began with former Yale President 
Richard Levin in the mid-1990s. He believed that Yale 
needed to engage more in the local economy. Between 
2006 and 2016, 233 medical school faculty members 
were awarded patents—many of which have been 
licensed to businesses. During the past 15 years, Yale’s 
Office of Cooperative Research (OCR) has helped 
launch an average of four to five local, venture-backed 
startups per year. To date, more than 50 startups based 
on Yale intellectual property have raised more than 
$700 million in venture capital. 
OCR and its companion program, the Yale Entrepre-
neurial Institute, run a wide variety of programs aimed 
at helping students and faculty establish companies. They 
make investments in startups and manage the Blavatnik 
Fund. They also introduce faculty to venture capital-
ists. The most recent major success: Lieping Chen, M.D., 
Ph.D., the United Technologies Corporation Professor 
in Cancer Research, raised $67 million last year for his 
startup NextCure. It was the largest initial funding ever 
for a New Haven-area biotech company. “We’re helping to 
create a density of interactions—people bumping into each 
other,” says Jon Soderstrom, Ph.D., managing director of 
OCR. “You have to have molecules bouncing off each other, 
because that’s how you create bonds.”
Yale supports other programs aimed at promot-
ing entrepreneurship. For instance, its Center for 
Biomedical and Interventional Technology, with par-
tial funding from the state, brings together engineers, 
scientists, clinicians, and entrepreneurs to develop 
novel approaches to address unmet health care needs. 
In January, about 200 aspiring entrepreneurs partici-
pated in its Healthcare Hackathon. The winner was a 
smartphone app that reads the facial expressions of 
military veterans at risk for post-traumatic stress dis-
order and alerts others if they show distress.
What’s in it for Yale? Not only does the university 
collect revenues from its patents ($8.3 million last fiscal 
year), but the potential for faculty researchers to partici-
pate in the startup economy is a major plus for recruit-
ment and retention. Also, many students want to explore 
entrepreneurship in parallel with their studies. Rothberg, 
the gene-sequencing pioneer, urges the university to 
brand itself as an incubator for entrepreneurship, which 
could strengthen both the university and the community. 
“We have a huge competitive advantage because of the 
medical school and the life sciences,” he says.
For New Haven, the biotech cluster represents the 
best opportunity for fostering a startup economy—and 
creating both scientific and supporting jobs. That’s 
why the city has made redeveloping the land between 
downtown and the medical school a top priority. 
Alexion’s headquarters is part of a much larger initia-
tive, Downtown Crossing, which is aimed at adding 
new office, residential, and laboratory space, and 
increasing pedestrian traffic along the Route 34 corri-
dor. The Route 34 highway project in the 1950s cut the 
city in half. Now government, Yale, and the business 
community are knitting it back together. 
For now, most of the trend lines are positive, and 
the people who are intent on building a flourishing 
biotech community in New Haven see a path forward. 
They speak of making the entire bioscience innova-
tion chain, from lab to marketplace, more “systematic.” 
The process of inventing in the academic laboratory 
must become faster—partly with the help of computer 
simulation, artificial intelligence, and data analytics. 
Scientists and engineers with great ideas must learn 
to be entrepreneurs. And ideas, capital, talent, and lab 
space must be brought together more efficiently.
To Crews, New Haven possesses a historic opportunity 
to create a competitive advantage over other places. “The 
process of moving science into the marketplace can’t be 
ad hoc. You have to fill the pipeline in a systematic way,” 
he says. “It’s like Eli Whitney and interchangeable parts, 
or Edison harnessing creativity on an industrial scale. We 
have to do the same—filling the innovation gap in the 
pharmaceutical industry and accelerating the founding of 
biotech companies.” /yale medicine
Steve Hamm is a managing editor at the YSM Office of 
Communications.
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in the fall of 2016, Tara Torabi met her first 
patient over the phone, a woman in her 30s with a 
muscle weakness that has stymied doctors. Since 
then Torabi has called her patient on the phone every 
week to check in and make sure she has transporta-
tion to her appointments and is taking her medications. 
Sometimes she calls just to make sure she’s OK.
When she calls, there’s always a third person on the 
line, an interpreter fluent in English and Arabic. The 
patient is a refugee from Iraq, and Torabi is a first-year 
medical student serving as her patient navigator.
Torabi is one of 18 medical students participating 
in the second year of a program that pairs them with 
patients from the School of Medicine’s refugee clinic 
for adults. The refugees, mostly from Afghanistan, Iraq, 
Syria, and Sudan, are referred through New Haven’s 
Integrated Refugee & Immigrant Services (IRIS), the 
largest of Connecticut’s three resettlement agencies.
“I have always felt that service is important,” said 
Torabi, who came with her family from Iran at the age 
of three and knows what it’s like to arrive in a strange 
country. “By participating in service activities, you 
really feel more connected to the community. It is an 
integral part of your education.”
The clinic (there’s another one for children) started 
about 10 years ago when a resident at Yale New Haven 
Hospital, herself an immigrant from Iraq, saw a need 
for services geared toward refugees. Two years ago, 
residents and medical students launched a pilot pro-
gram to help patients navigate what can be a complex 







health care system. All refugees go through a health 
vetting before they enter the United States, but they 
also need a domestic vetting on arrival. The screenings 
check for tuberculosis and other diseases, and ensure 
that the patients have been vaccinated. “The idea is 
not to keep them from entering the country,” says Ani 
Annamalai, M.D., assistant professor of psychiatry and 
of internal medicine, and director of the clinic, “but to 
get them the necessary treatment.”
Many patients, said Amir Mohareb, M.D., HS ’17, are 
also at risk of post-traumatic stress disorder. “Even the 
most resilient refugees end up struggling to assimilate 
here,” said Mohareb, the resident leader for the pro-
gram. “There is some level of psychological distress in 
every refugee.”
The clinic sees up to 250 families each year, about 
five patient visits each week. After their screening for 
medical conditions, the families are integrated into the 
health care system. That’s where the patient navigators 
enter the picture. Since the pilot program was launched 
in 2015, it has grown from 10 student volunteers to 18. 
Paul Bourdillon, a third-year medical student and one 
of the program’s two coordinators, said that it provides 
a clinical experience for “preclinical students who 
haven’t had much patient contact, but have some medi-
cal knowledge and some understanding of the way the 
medical system works.” The patient navigators, added 
Amandine Godier-Furnemont, a second-year student 
and the other program coordinator, serve as “a bridge 
between physicians and patients.”
Chris George, the director of IRIS, said that the rela-
tionship with Yale has made his organization the envy 
of other resettlement groups around the country—New 
Haven has a world-class medical center with staff dedi-
cated to helping refugees on a regular basis. The resettle-
ment process helps families find jobs, learn English, find 
their way around the city, find apartments, and learn 
about health through nutrition and wellness classes. 
IRIS also refers patients to the refugee clinic.
Last year, IRIS went from resettling about 240 peo-
ple per year to 530. “The world was facing the largest 
refugee crisis ever,” George says.
Among the families resettled last year was Torabi’s 
patient, who came with her mother, husband, and 
children. The first time Torabi met her patient in 
person was at a medical appointment in January. “It 
was slightly awkward because the translator wasn’t 
there,” Torabi says. “It was difficult to connect, but 
there are other ways to communicate. You can smile 
and touch their shoulder.”
Her patient, Torabi said, was grateful for her pres-
ence. “Just showing up is important. Just showing 
someone that you care about them is meaningful, even 
if it seems like a small thing.”
Torabi helped her patient arrange an appointment 
with a neurologist to investigate the muscle weakness 
that required her to use a wheelchair. When she learned 
that her patient’s wheelchair had broken and that she 
was sharing one with her mother, Torabi pressed the 
primary care doctor for a prescription for a new one.
“This experience has sustained me and reminded me 
of why you enter med school in the first place,” Torabi 
says, “to help people.” /yale medicine
John Curtis is the editor of Yale Medicine.
Last year two medical 
students, at left, Tara Torabi, 
and Paul Bourdillon, were 
part of a patient navigator 
program to help newly ar-
rived refugees find their way 
through a complex health 
care system. The two physi-
cians at right, Amir Mohareb, 
a resident in internal medi-
cine, and Aniyizhai Annama-
lai, an assistant professor of 

















  Like dissection,  
but without the mess
One of the newest acqui-
sitions in the Medical 
Historical Library is in an 
elegant wooden case, about 
3 feet on each side, that 
opens to reveal a paper 
model of a 5-foot-9-inch 
naked man with brown hair, 
blue eyes, and rosy cheeks. 
The case is a “deluxe” 
German edition of White’s 
Physiological Manikin, a 
flap anatomy designed by 
author and publisher James 
T. White in 1886.
Melissa Grafe, Ph.D., 
the John R. Bumstead 
tissue or paper flap can be 
lifted to reveal the layer 
underneath. The manikin’s 
multiple layers of flaps rep-
resent muscle, bone, and 
organs all the way down 
to the spinal cord. Prior to 
the new purchase, which 
arrived at Yale in November 
2016, the library had sev-
eral flap anatomies already, 
but the new addition is 
the largest among them. 
“There’s nothing like this in 
the collection itself; there’s 
just nothing to compare,” 
Grafe said.
  A life-size “lift-the-flap” model of the human  
 form joins the medical library’s collection.
 By Ashley P. Taylor
Librarian for Medical 
History and head of the 
Medical Historical Library, 
spotted the manikin, titled 
Dr. Franke’s Phantom, 
among the online offerings 
from a British dealer last 
October and knew that it 
belonged in Yale’s collec-
tion. The Cushing/Whitney 
Medical Library already 
had a strong collection of 
anatomical books, Grafe 
said, thanks in large part to 
library namesake and neu-
rosurgeon Harvey Cushing, 
M.D., who collected them. 
But Dr. Franke’s Phantom 
is not your typical ana-
tomical volume. It’s a flap, 
or lift-the-flap anatomy, 
in which each layer of 
According to Grafe, 
flap anatomies, which 
date back to the 16th 
century, gave medical 
students and interested 
laypeople a simulation 
of dissecting a three-
dimensional body—with-
out the mess of a cadaver. 
Dr. Franke’s Phantom, 
which can hang on the 
wall, was likely used in 
its day for traveling lec-
tures, in doctors’ offices, 
and in anatomy class-
rooms, Grafe said. “You 
can just imagine people 
looking at this—and it’s 
life-size—walking up to it 
and being amazed at the 
complexity of the human 
body,” Grafe said.
In 2016 the Historical Library 
acquired an 1891 deluxe German 
edition of White’s Physiological 
Manikin, a lift-the-flap anatomy 
first published in 1886. In its day, 





bears a stamp of medical 
approval from Frank H. 
Hamilton, M.D., one of four 
physicians who attended 
to President James A. 
Garfield after he was 
shot in 1881; the name Dr. 
Franke’s Phantom likely 
refers to Hamilton, Grafe 
said. The German edition 
is considered deluxe, Grafe 
said, because underneath 
its male exterior, it con-
tains flaps for both male 
and female genitalia, plus 
a womb with a fetus inside. 
Additional flaps illustrate 
the positions of hands and 
forceps during delivery.
Anyone at Yale, as well 
as outside researchers, can 
request to use the manikin 
at the Medical Historical 
Library. By the end of 
its first month at Yale, a 
FAR LEFT The manikin’s flaps can be 
lifted like pages in a book to reveal 
muscle, bone, and organs beneath 
the skin. This image depicts a sur-
geon’s scalpel cutting through skin 
on the leg.
LEFT Although ostensibly a 5-foot-
9-inch male, the manikin includes, 
underneath several flaps, a womb 
and fetus. It also includes both male 
and female genitalia.
BELOW The flaps lift up to reveal 
successive layers of the human body, 
right down to the brain, skeleton, 
and central nervous system.
student had already used 
the manikin to research a 
paper about flap anatomies, 
and Grafe had displayed it 
for the Society of Clinical 
Surgery’s 2016 annual 
meeting at the School of 
Medicine. “We can envi-
sion all kinds of uses for 
this,” Grafe said.
The manikin is 
unlikely to appear, how-
ever, in the anatomy 
classroom: Outside the 
anatomy lab, Yale medical 
students use a computer 
resource available at the 
medical library called 
VH Dissector Pro, which 
Grafe describes as “the 
modern equivalent of lift-
the-flap,” which allows 
students to rotate struc-
tures in space. But along-
side contemporary tools, 
flap anatomies retain  
their places in libraries 
due to their historical 
value. They even have  


















 Starting from scratch
»
long before “patient-centered care” was com-
mon parlance in the medical profession, Bonita Stanton, 
M.D. ’76, was practicing it in the slums of Dhaka, 
Bangladesh. A staff scientist and director of the urban vol-
unteer program at the International Centre for Diarrhoeal 
Disease Research, Bangladesh (icddr,b) in the 1980s, 
Stanton organized poor, mostly illiterate village women 
as research assistants in a case-control study that led to 
significant reductions in diarrhea among village children. 
“It didn’t take much to realize 
that I couldn’t design the study,” 
said Stanton. “The women had 
to help me because I didn’t know 
anything about their culture and 
their circumstances.” So Stanton 
put them on her team. 
Throughout her career, 
Stanton has relied on team-
work to face challenges outside 
her comfort zone. When she 
returned from Bangladesh in 
the late 1980s at the height of 
the rise of the HIV epidemic, 
she harnessed the expertise of 
inner-city Baltimore youth and 
recreation center directors to 
devise a program for prevent-
ing risky sexual behaviors. 
She brings that collaborative 
spirit to her latest endeavor 
as founding dean of Seton 
Hall University-Hackensack 
Meridian School of Medicine, 
the first private medical school 
in New Jersey, which is set to 
open in the summer of 2018.
“It really matters to be able to 
collect the right people in your 
cabinet,” Stanton said of starting 
a medical school from scratch. 
The pediatrician and infectious 
disease specialist has hired most 
of her cabinet, and department 
chairs have also been appointed. 
Leadership of the fledgling medi-
cal school is now hiring faculty 
members to add to the many who 
will come from within Seton 
Hall University and Hackensack 
Meridian Health, an integrated 
health care system in New Jersey. 
The 55 students of the new 
school’s inaugural class will 
study in the research facility 
that once housed Swiss pharma-
ceutical company Hoffmann-La 
Roche. The six-story building 
that straddles the New Jersey 
town of Nutley and the city of 
Clifton is already steeped in 
medical history—Valium and 
interferon were discovered there. 
The curriculum, which will 
prepare future doctors to pur-
sue any medical specialty, is 
currently a work in progress. 
Stanton’s cabinet and about 
150 Seton Hall faculty members, 
including basic scientists, physi-
cian and non-physician health 
care professionals, lawyers, 
social workers, and communica-
tions experts, are developing a 
course of study that reflects the 
school’s vision: “Each person 
in New Jersey, and in the U.S., 
regardless of race or socioeco-
nomic status, will enjoy the 
highest levels of wellness in an 
economically and behaviorally 
sustainable fashion.”
The vision embodies the val-
ues of Stanton’s career, which 
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faces
Since graduating from 
the School of Medicine 
in 1976, Bonita Stanton 
has fought diarrhea 
in Bangladesh and 
devised programs to 
prevent risky sex in Bal-
timore. Now she’s the 
founding dean of the 
Seton Hall University-
Hackensack Meridian 
School of Medicine, the 
first private medical 
school in New Jersey.
there from their current location 
in South Orange. “Part of the 
reason for the high cost of care 
is that we have not been skilled 
in working as a team with our 
professional counterparts across 
disciplines,” said Stanton, refer-
ring to nursing, occupational 
and physical therapy, and related 
fields. “We must learn very early 
on to deliver care in a team, and 
the best way to do that is to be 
trained that way.” 
The curriculum will also 
stress appropriate use of care 
settings, from doctors’ offices to 
hospitals—another means  
she has spent combating health 
disparities and caring for the 
disenfranchised. Stanton has 
taken adaptations of the HIV 
prevention program she created 
in Baltimore to China, Namibia, 
and Vietnam, among other 
countries in Africa and Asia. 
Concurrent with her position at 
icddr,b, she was a maternal and 
child health specialist at the 
World Bank. 
“It’s all about servant leader-
ship: serving people and work-
ing together to find the best way 
to serve,” she said. “That belief 
is at Seton Hall University’s core, 
and it really aligns with how I 
see medicine as well.” 
To realize the school’s vision 
of equal access to care for all at 
a reasonable cost, Stanton again 
points to the importance of 
teams. The new medical school’s 
curriculum will emphasize col-
laborative learning and collabor-
ative care—the College of Nursing 
and School of Health and Medical 
























of making care more efficient 
and affordable. 
Establishing the mission and 
vision for the school, said Stanton, 
is a critical challenge in starting 
a medical school. “The mission 
and vision define the entire fabric 
and constitution of the school. But 
this critical challenge is also what 
makes the opportunity to start 
a school so wonderful: You start 
with a blank slate.” 
Stanton relishes the oppor-
tunity to start from scratch, she 
said, because it gives her the 
opportunity to make her own 
mistakes rather than be restricted 
by the past mistakes of others. 
She gives the School of Medicine 
much of the credit for her comfort 
with uncharted territory. 
“Yale Med’s educational format 
made it so much more likely that 
its graduates could step into a 
situation (such as starting a new 
medical school) with few guide 
rails or established paths and 
design the best routes for our 
purposes,” Stanton said. “At Yale 
we weren’t studying for grades 
because there were no grades. 
We were studying to learn.”
—Sonya Collins
»
A polymath’s perpetual 
adventures 
Michael Singer, Ph.D. ’00, M.D. ’02, 
is a self-described “serial entrepre-
neur” who has co-founded not one 
but several health- and medicine-
related companies. Accordingly, 
his claim to fame is not a single 
accomplishment, but rather the 
diversity of his skills and inter-
ests. At both Yale College and the 
School of Medicine, he excelled in 
neuroscience, medicine, and art 
history; developed a love for travel; 
and studied multiple languages. 
Former professors laud his intellect 
and accomplishments. But on top 
of all that, they mention some-
thing else. “He’s also such a nice 
guy,” said Singer’s mentor, Gordon 
M. Shepherd, M.D., D.Phil., profes-
sor of neuroscience, “When you 
combine that with his unbounded 
curiosity and abilities, I think it 
made for a wonderful basis for 
doing what he’s done.” 
Singer grew up in DuBois, a 
resource-poor town in west-
ern Pennsylvania. Childhood 
asthma motivated him to pursue 
medicine, and he applied to Yale 
College because it was ranked first 
in U.S. News & World Report, a 
decision he describes as being 
“right for the wrong reasons.”
At Yale College, Singer 
needed a work-study job, and 
during his sophomore year spot-
ted two postings related to biol-
ogy on the post office bulletin 
board: one to wash glassware 
and do cell-culture work, one 
to work in Shepherd’s lab doing 
computer modeling of how 
odor molecules interact with 
neuronal receptors. He jotted 
down the first number and went 
back to his room to call, only 
to find the post had been filled. 
“So there I was: It was pour-
ing rain outside, and I decided 
that I should go back to the post 
office.” He called Shepherd’s 
lab, got the job, worked there 
as an undergraduate, then did 
his Ph.D. there, writing a thesis 
whose title was “almost exactly 
the job description that I had 
found in the post office.”
Shepherd became more than 
a scientific mentor. He also “got 
me exposed to the rest of the 
world,” Singer said, facilitating 
trips to work with collaborators 
in Germany, Brazil, and Israel. 
Though his studies focused 
on science and medicine, sci-
ence was by no means all Singer 
did. During his senior year, he 
studied Mayan art with Mary 
Miller, M.A. ’78, Ph.D. ’81, 
Sterling Professor of History of 
Art, and senior director of the 
Institute for the Preservation of 
Cultural Heritage. “The course 
involved Mary taking us around 
and looking at these pots in 
the museum,” Singer recalls. 
“What a great way to spend your 
time in a course at Yale.” Miller 
encouraged Singer to pursue art 
history, Shepherd remembered. 
“It was fun to think that I was 
competing with the art world for 
Mike’s abilities,” he said.
During Singer’s M.D./Ph.D. 
program—which he completed 
in just seven years—he con-
tinued to branch out, studying 
Hindi, Spanish, Portuguese, 
archeology, and parasitology. 
He went to Pakistan on a Downs 
Fellowship, where he studied 
the epidemiology of childhood 
injuries. In preparation for that 
trip, he studied yet another lan-
guage, Urdu. 
During his medicine intern-
ship at Brigham and Women’s 
Vivek Murthy, M.D. ’03, 
M.B.A. ’03, out as 
Surgeon General
Just over two years 
into his four-year term, 
Murthy was removed 
from his post as 
Surgeon General. He 
was asked to resign 
after assisting with 
the transition to the 
administration of Pres-
ident Donald Trump.






His next endeavor is Cartesian 
Therapeutics, which develops 
cancer therapies. 
His Yale education, Singer 
said, encouraged the interests 
that have led to business success 
(not to mention personal enjoy-
ment). “The faculty don’t want 
you to focus too much on any one 
thing,” he said. “I think that atti-
tude is what puts you in a position 
to explore new opportunities as 
an adult. I haven’t had a career 
to speak of, really; I just keep 
on moving from one interesting 
adventure to the next.”
—Ashley P. Taylor
As a Yale undergrad, 
Michael Singer was 
torn between art his-
tory and medicine. He 
entered the M.D./Ph.D. 
program and since his 
graduation in 2002 
has launched several 
companies that make 
therapeutic devices 
and software.
Hospital in Boston, a patient 
with severe asthma attacks told 
Singer that his inhaler, which 
he had been overusing, was 
empty. If physicians knew 
when a patient’s inhaler was 
being heavily used and when 
that patient was having breath-
ing problems, Singer theorized, 
perhaps they could predict and 
avert asthma attacks. Singer’s 
first invention was a “smart” 
inhaler that uses cellular tech-
nology to tell a physician how 
much the inhaler is being used. 
During Singer’s residency in 
the Harvard ophthalmology 
program he met his wife, 
Baharak Asefzadeh, O.D., M.S.
He went on to launch 
HealthHonors Corporation, 
which creates behavioral eco-
nomics software to encour-
age people to make healthful 
choices. He sold that com-
pany to Healthways in 2009. 
Later, he founded Topokine 
Therapeutics, which developed 
topical treatments to reduce 
fat in undereye bags. Topokine 
















Determined to better under-
stand infant and child develop-
ment, Mayes arrived at Yale in 
1982 for a second fellowship in 
pediatric clinical research. She 
planned to return to Tennessee 
to care for preterm children 
and their families. Instead, she 
stayed in New Haven, where she 
was mentored by renowned psy-
chologists and behavioral and 
developmental pediatricians.
Mayes, now the Arnold Gesell 
Professor of Child Psychiatry, 
Pediatrics, and Psychology, 
runs a behavioral neuroscience 
laboratory that has followed 
children and their families over 
20 years. She has also developed 
interventions for at-risk families.
With colleagues across the 
pond, Mayes helped establish 
the Yale—University College 
London master’s program in 
developmental neuroscience and 
psychopathology. Since 2007, 
she’s served as special advisor 
to Dean Robert J. Alpern, M.D., 
Ensign Professor of Medicine. She 
continues to serve as principal or 
co-investigator on multiple clini-
cal trials, including one on the 
neural circuitry of mothers who 
have abused cocaine. In 2016, 
she was named director of the 
106-year-old Child Study Center. 
Since her appointment, 
Mayes has met with researchers 
and physicians across the school 
to build interdepartmental col-
laborations among the center’s 
25 disciplines with a focus on 
improved mental health care 
for children and families. “The 
most rewarding part of my job 
now is bringing people together 
and capturing their excitement 
around what we could do, where 
we could go—to try and imagine 
the Child Study Center 10 and 
20 years from now.”
  Linda Mayes’ journey to  
 leading the Child Study Center
watch an interview  





W H I L E T R A I N I NG A S A N E ONAT OL O GI S T at Vanderbilt 
University Medical Center in Nashville, Linda C. Mayes, 
M.D., FW ’85, cared for preterm infants born to rural 
families in her home state of Tennessee. Some babies 
weighed barely two pounds. “Seeing families come to 
grips with having to send their 800-gram baby many 
miles away taught me a lot about the complex systems of 
health care for seriously ill children and their families,” 
said Mayes, director of Yale’s Child Study Center.





How has our understand-
ing of child development 
and child mental health 
evolved? We now have 
a far better understand-
ing of how life experience 
can affect genetic regula-
tion. We know that early 
trauma and adversity 
shape the emerging brain 
and have lifelong implica-
tions not just for physical 
health but also for well-
being, mental health, and 
overall life success. The 
old metaphors of nature 
versus nurture are com-
pletely outdated. We take 
a lifespan perspective and 
attempt to understand 
how childhood events 
carry into adulthood and 
potentially into the next 
generations as children 
become adults and raise 
their own children. 
What are some of the 
center’s major achieve-
ments in research? The 
center began under found-
ing director Arnold Gesell, 
Ph.D., M.D. 1915, whose 
innovative idea was that 
a child’s cognitive, social, 
and motor abilities unfold 
in a predictable and 
ordered way, as do physical 
growth and physiological 
capacities. The Child Study 
Center was at the forefront 
of these early developmen-
tal ideas and helped shape 
prominent ideas around 
children’s mental health in 
the 1960s and 1970s. By the 
1980s, the center was lead-
ing the way in defining 
characteristics of child-
hood psychiatric disorders, 
including autism. In the 
1990s, center researchers 
were conducting clinical 
trials on new pharma-
cological agents to treat 
childhood psychiatric 
disorders and beginning 
to investigate the genetic 
basis of these disorders. 
Today, we are at the fore-
front of understanding, 
for example, the neural 
basis of social development 
or how early childhood 
trauma can have a lifelong 
impact on key neural and 
immune systems. 
How far along has the 
center’s clinical restruc-
turing progressed? We 
have begun to change our 
infrastructure so our clini-
cians work in what we are 
calling a group practice. 
We will be able to have 
more collaboration across 
our specialty services and 
better cross-training for 
our fellows and our faculty. 
We are looking for one 
unified space to bring all of 
our services together, but 
even before we have that, 
we are designing our prac-
tice together and begin-
ning to change the ways 
families are able to access 
our services. 
The center has been a 
pioneer in developing 
community programs. 
How do these differ 
from other public pro-
grams? We distinguish 
ourselves by our range of 
our services—from pro-
viding specialty expertise 
around very specific child-
hood disorders such as 
autism, anxiety, Tourette’s 
syndrome, and post-trau-
matic stress disorder in 
children, to providing in-
home services and serving 
parents and moms in the 
community. In our portfo-
lio of services, we address 
concerns across genera-
tions. For example, we are 
opening a parenting cen-
ter called the Parent and 
Early Family Development 
Program. When an adult 
becomes a parent, there’s 
an enormous amount of 
development going on at 
the psychological level and 
at the brain level. We’re 
interested in offering 
specific services to adults 
in their role as parents 
as these will positively 
impact their children.
These days it seems that 
kids are always staring 
into their mobile devices. 
Do we know whether 
these habits will affect 
development? At this 
point, we don’t really 
know. Never has the 
world of information 
been more accessible in 
such a rapid way to chil-
dren. They will naturally 
gravitate toward and use 
technology. We do know 
that relationships are 
important for healthy 
brain development in 
children. Relationships 
open up and translate the 
world for children; for 
example, using the iPad 
to FaceTime with grand-
parents or uncle or aunt. 
Contextualizing the tech-
nology puts it inside rela-
tionships, which we know 
are absolutely essential 



















{ To nominate a subject for Q&A, contactYale Medicine, 1 Church Street, Suite 300, New Haven, CT 06510 or email ymm@yale.edu
   Why sleep  
 matters
    By Cathy Shufro
Meir H. Kryger, M.D., was giv-
ing a morning lecture on sleep 
disorders when he spotted the 
physician who’d invited him 
to speak slouched in the front 
row, deep in slumber.
Kryger approached his 
host, woke him, and began to 
interview him. “I wanted my 
audience to learn how to ask 
questions about sleepiness,” 
recalled Kryger, a professor 
of medicine (pulmonology) 
at the medical school. When 
Kryger asked, “Do you ever fall 
asleep while driving?” his host 
replied, “Doesn’t everybody?”
“A lot of people don’t 
appreciate that they have a 
symptom that can be really 
significant—and dangerous,” 
said Kryger in an interview. 
(Sleepy drivers cause one in 
five car crashes.) To help read-
ers recognize sleep disorders 
in themselves and in people 
around them, Kryger has 
written The Mystery of Sleep: 
Why a Good Night’s Rest Is 
Vital to a Better, Healthier 
Life. The book discusses sleep-
related phenomena, including 
sleep apnea, nightmares, sud-
den infant death, and rest-
less legs syndrome. The book 
explains how to minimize 
the harms of shift work, lists 
“the thirteen commandments 
for fighting insomnia,” and 
outlines a plan for minimizing 
jet lag. Kryger also considers 
“secondhand sleep problems,” 
addressing the travails of  
bedmates whose partners 
snore, grind their teeth, or 
fidget nonstop. 
Like the doctor who 
snoozed during that lec-
ture, Kryger said that many 
people don’t recognize that 
drowsiness could signal 
a serious sleep disorder 
or even a disease such as 
cancer. And sometimes the 
signs aren’t obvious: Falling 
asleep in a movie theater 
can suggest a sleep prob-
lem, but so can moodiness, 
memory lapses, or dreaming 
while half awake. Readers 
can rate the probability that 
they suffer from a disorder 
by using the book’s modified 
Epworth Sleepiness Scale. 
For those who go on to seek 
medical advice, Kryger 
warns against speaking in 
generalities: Rather than 
saying, “I’m tired,” patients 
should specify changes in 
mood and behavior.
Women report more sleep 
problems than men do. In a 
National Sleep Foundation 
poll, 60 percent of the thou-
sand women questioned said 
they slept well only a few 
nights per week. Kryger says 
women are often misdiag-
nosed, however; doctors con-
clude that they are depressed 
when their symptoms actu-
ally suggest a sleep disorder.
Women constitute about a 
third of the roughly 7.4 million 
Americans believed to have 
obstructive sleep apnea, in 
which blocked airways cause 
snoring and pauses in breath-
ing during sleep. The condi-
tion can lead to heart disease 
and other serious illnesses. 
Although sleep apnea affects 
not only women but babies 
and children and even snub-
nosed dogs such as Boston 
terriers, the stereotypical sleep 
apnea sufferer is an overweight 
older man. As a result, Kryger 
said, women with apnea are 
often misdiagnosed as suffer-
ing from depression. He called 
that “a failing of the medical-
education system. Doctors do 
not know enough about sleep.”
Undergraduates show 
a keen interest in the topic, 
however. When Kryger 
offered a class on sleep at Yale 
College last fall, more than 
100 students vied for 18 spots. 
Similarly, undergraduates 
flock to Stanford’s “Sleep and 
Dreams” course, where Kryger 
recently guest-lectured; the 
class has been taught since 
1970, and former students 
include psychologist and Yale 
President Peter Salovey. 
The Mystery of Sleep notes 
that President Barack Obama 
rarely got the seven to nine 
hours of sleep recommended 
for adults. Kryger quotes 
then-President Obama as say-
ing that when his term ended, 
“I’m going to take three, four 
months where I just sleep.” 
Kryger said that insufficient 
sleep can be risky in presi-
dents, because it may cause 
irritability and impulsivity.
As for Kryger himself, he 
usually manages to get at 
least seven hours of sleep. He 
recommends heeding a col-
league’s caveat: “If you don’t 


































{Send notices of new books toYale Medicine, 1 Church Street, Suite 300, New Haven, CT 06510 or email ymm@yale.edu
book review
S I NC E T H E E L E C T ION OF PR E S I DE N T D ONA L D T RU M P in November, medical stu-
dents at Yale have joined with others around the country to support the Affordable 
Care Act (ACA). The Yale Healthcare Coalition held rallies, organized phone banks to 
contact politicians, wrote opinion pieces for their hometown newspapers, and met 
with Connecticut senators and representatives. Their elation when the Republican 
Congress failed to repeal the ACA in March turned to disappointment in May, when 
a replacement bill, the American Health Care Act, narrowly passed. The students 
vowed to continue fighting for health care for all. “It is important to remember,” said 
student Karrin Weisenthal, “that this isn’t an intellectual debate. There are real peo-
ple and real lives that are going to be paying the price of this vote.”
On Jan. 9 medical students gathered on the steps of the Sterling Hall of 
Medicine to take part in a national moment of silence in support of the ACA.
—John Curtis
 Fighting for Obamacare
end note
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